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Abstract 
Pharmaceutical glycoproteins are one of the fastest growing therapeutic areas 
and glycosylation plays an important role in biological activity of the drugs. Most 
of the currently used therapeutic glycoproteins are expressed in non-human 
systems, often producing glycosylation patterns which can reduce the 
effectiveness and stability of the drugs or cause immune responses in patients. 
Due to the structural complexity of glycans, glycosylation analysis remains 
extremely challenging and frequently employs multiple separation and mass 
spectrometry based approaches. The standard approach for glycan profiling 
currently used in the pharmaceutical industry includes fluorescent labelling of 
enzymatically-released glycans and separation with hydrophilic interaction 
liquid chromatography (HILIC) coupled with fluorescence detection to achieve 
appropriate chromatographic resolution, sensitivity and relative quantification.  
In this study, new methods employing zwitterionic-type HILIC (ZIC-HILIC) for 
the separation of 2-aminobenzamide (2-AB) labelled and reduced glycans from 
therapeutic monoclonal antibodies were developed. By using the new approach, 
the time of a chromatographic run was reduced compared to the standard 
method and the new proposed methods were suitable for on-line coupling with 
electrospray ionisation mass spectrometry detection (ESI-MS). Furthermore, it 
was demonstrated that by using ZIC-HILIC, fluorescent labelling was not 
required which significantly simplified the sample preparation.  
To improve ESI-MS sensitivity of reduced glycans, the system was further 
downscaled employing nano ZIC-HILIC, which enabled the detection of minor 
glycan species. It was shown that coupling with high resolution MS provides 
information on glycan composition; however, due to high numbers of possible 
isobaric species, the confirmation of structures generally requires separation of 
glycans in combination with exoglycosidase digestions and tandem MS based 
approaches.  
  
III 
 
The HILIC analytical approaches were additionally compared to an orthogonal 
porous graphitized carbon (PGC) separation of reduced glycans coupled with 
ESI-MS. PGC exhibited excellent capability for the separation of isobaric glycan 
species and better sensitivity compared to HILIC. It was demonstrated that PGC 
is highly suitable for analysis of extremely complex glycan samples and the 
method was employed for structural characterisation of glycan species found in 
monoclonal antibodies. Since the PGC ESI-MS method resulted mainly in 
formation of protonated glycan species, the MS/MS spectra provided only 
limited structural information. On the other hand, exoglycosidase digestions 
enabled detailed characterisation of glycans from monoclonal antibodies. It was 
shown that multiple analytical approaches are generally required to obtain a 
complete glycan profile of a given glycoprotein.  
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Introduction 
The aim of this project is the development of new methods for glycosylation 
analysis of recombinant monoclonal antibodies (MAbs). MAbs and glycoproteins 
in general are one of the fastest growing therapeutic areas and their activity, 
stability, serum half-life and adverse reactions in patients are largely determined 
by glycosylation. Currently, there is no single method that could provide 
complete information on glycan profile, due to the complexity of glycan 
composition, structures and linkages. The sample preparation in glycosylation 
analysis is usually laborious and it can involve derivatization steps that are 
expensive and time-consuming. At the same time, numerous separation-based 
analytical approaches have been developed to provide detailed information on 
MAbs glycosylation and the current standardised separation procedures used in 
pharmaceutical industry require from several minutes to several hours. Since in 
quality control and clone selection high numbers of samples are being routinely 
analysed, there has been a lot of interest in improving and optimising current 
analytical methods.  
The same principles of glycosylation analysis as in pharmaceutical industry 
apply also to the rapidly developing field of glycomics, the younger sibling of 
genomics and proteomics, where the entire range of sugars and their 
physiological and pathological aspects in a given organism are being studied. All 
these areas of glycobiology and pharmaceutical analysis require rapid, sensitive 
and quantitative analysis of glycan composition, structure and linkages. 
The project is focused on several aspects of glycosylation analysis, including 
simplification of sample preparation, enhancing sensitivity of mass spectrometry 
(MS) detection by miniaturisation with emphasis on analysis of minor glycan 
species, comparing different stationary phases in order to achieve optimum 
selectivity, and employing enzymatic and mass spectrometry-based approaches 
for structural elucidation of glycans. The strategies and techniques used in this 
study are schematically represented in Figure 0–1. 
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Figure 0–1: Schematic representation of methods used in this study. 
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Chapter One 
 1. Literature review 
Post-translational modifications (PTMs) are covalent modifications that change 
the properties of a protein by proteolytic cleavage or by addition of a modifying 
group to one or more amino acids. PTMs determine activity and localization of 
the protein, and interactions with other proteins [1]. Protein modifications are 
generally not homogeneous, and expression of a single gene can result in a large 
number of gene products [1]. The main PTMs associated with proteins are 
acetylation, acylation, carboxylation, hydroxylation, amidation, disulphide bond 
formation, glycosylation, phosphorylation, sulfation and proteolytic processing 
[1] and many of them are relevant also to therapeutic proteins [2]. The majority of 
approved therapeutic proteins, such as blood factors, anticoagulants, antibodies, 
hormones, erythropoietin and interferons, bear some form of PTMs [2]. 
1.1. Glycosylation 
Glycosylation is a very versatile post-translational modification and contributes 
to the complexity of protein molecules. Glycosylation determines biological 
activity and function of proteins and it has an important influence on their 
physicochemical properties [3, 4]. Malfunctions of glycan biosynthetic pathways 
lead to numerous disorders which indicate the importance of glycosylation in 
biological processes [5].  Several types of glycosylation are known and the most 
common and well-studied are O- and N-glycosylation. The N-linked glycans are 
attached to an asparagine residue via a (Man)3(GlcNAc)2 core (where Man 
represents mannose and GlcNAc represents N-acetylglucosamine) and they are 
divided into the three main classes; high mannose, complex and hybrid type 
glycans (Figure 1–1). High mannose glycans have only mannose residues 
attached to the core, complex glycans have antennae starting with GlcNAcs, and 
hybrid glycans have one or two antennae attached to the 3-arm and mannose 
Chapter One  Literature review 
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residues at the 6-arm [4]. Most of the N-glycans are synthesised from a common 
precursor containing the (Glc)3(Man)9(GlcNAc)2 residue. After the attachment to 
the protein, glycans are further exposed to the glucosidases and mannosidases 
which give the high mannose glycans with 5 to 9 mannose units as the final 
products of the processing (Figure 1–2). The glycans with the GlcNAc added to 
the terminal region are called complex type. In mammals, the antennae are 
commonly elongated by galactosylation and capped by sialylation or 
fucosylation. The additional fucosylation site is the core GlcNAc. Compared to 
the high mannose glycans, the complex glycans exhibit greater diversity [4, 6]. 
This thesis is mainly focused on N-glycosylation and N-glycan profiling of 
mammalian glycoproteins from natural sources and recombinant therapeutic 
glycoproteins with emphasis on monoclonal antibodies (MAbs). However, the 
same principles of the glycosylation analysis apply to glycomics research, where 
the entire range of saccharides and their physiological and pathological aspects 
in a given organism are being studied.  
 
Figure 1–1: Chemical diversity of N-glycans with the most common representatives, (a) 
high mannose, (b) complex and (c) hybrid glycans. The structures are presented 
according to the scheme proposed by Consortium for Functional Glycomics [7]. The 
schematic representation has still not been unified [8]. 
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Figure 1–2: Biosynthesis on N-glycan side chains adapted from Dwek et al. [9].  Glucose;  N-acetylglucosamine;  Mannose. • • • 
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Most of the therapeutic MAbs belong to the IgG subclass, with a basic structure 
that consists of two light and two heavy chains associated with covalent and non-
covalent interactions, forming three regions. Two identical variable (Fv) regions 
express antigen-binding specific site and the constant region (Fc) determines 
interaction with effector molecules which results in the elimination of the antigen 
[10]. Monoclonal antibodies used in the treatment of cancers were primarily 
designed to target tumour antigens mainly involved in growth and proliferation 
of cancer cells and the main mechanism of action involved interaction with the 
antigen through the antigen-binding region of the MAb. Since it was established 
that the MAb anti-cancer activity can be enhanced by Fc mediated effects, which 
include killing the tumour cells via Antibody-dependent cytotoxicity (ADCC), 
Complement-dependent cytotoxicity (CDC) and Antibody-dependent 
phagocytosis (ADCP), novel approaches of engineering and optimising MAb 
activity have been developed. The main focus lies in enhancement of Fc effects 
through modifications of glycosylation and identifying Fc amino acid sequences 
for mutagenesis [11, 12]. Another important aspect of glycosylation of 
therapeutic glycoproteins is its effect on the in vitro and in vivo stability. The 
effects of glycosylation on proteolytic degradation, oxidation, chemical cross-
linking and physical stability of glycoproteins have recently been reviewed [13].  
A major general issue in MAb therapy has been immunogenicity, which 
originates either from the protein sequence or post-translational modifications, 
such as glycosylation. To minimize unwanted side-effects and increase efficiency, 
development of MAbs therapeutics has moved from highly immunogenic 
murine to more human-like chimeric, humanised and fully human MAbs [14]. 
The recombinant MAbs are most commonly expressed in Chinese hamster ovary 
(CHO) and murine myeloma cells (NS0 and Sp2/0), which exhibit glycosylation 
patterns slightly different to those found in humans. While the most common 
glycans found in human polyclonal IgGs are of the biantennary complex type 
with various levels of core-fucose, galactose, bisecting N-acetylglucosamine and 
N-acetylneuraminic acid, IgGs expressed in CHO cell lines exhibit glycan profiles 
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with a higher degree of fucosylation and lower level of galactosylation. On the 
other hand, IgGs expressed in murine cell lines contain some glycan forms that 
are not present in humans and that can be immunogenic [10, 15, 16]. In murine 
systems but not in human, an active α-galactosyltransferase is expressed, which 
adds a terminal α-galactose to the β-galactose at the end of the antennae of 
complex glycans and it can sensitize patients if the drug is administered on the 
chronic basis [17, 18]. It has been generally accepted that CHO cell lines do not 
have all the enzymes required for synthesis of glycoproteins with α-galactose 
epitope; however, the presence of α-galactose in CHO cell line has been recently 
confirmed [19]. The α-galactose levels in CHO glycoproteins are generally lower 
compared to those expressed in murine cell lines and it is believed that subclonal 
populations from the same parental cell lines can differ in the expression of the 
gene for α-galactosyltransferase [19]. The other unusual glycan species found in 
glycoproteins from murine cells is N-glycolylneuraminic acid (NeuGc), which 
was also shown to be immunogenic [20]. Very recently, it has been reported that 
the presence of NeuGc in MAb can reduce serum half-life of the drug and 
consequently its efficacy [21]. It was suggested that the level of NeuGc in 
recombinant glycoproteins can be reduced simply by adding NeuAc in the 
culture medium, which would compete with the pre-existing NeuGc. This would 
be a much simpler solution than changing the cell lines that have already been 
approved by regulatory agencies [21]. On the other hand, the effect of high 
mannose glycans that are normally present in MAbs expressed in murine and 
CHO cells in low amounts is still unknown. It has been suggested that 
mannosylation can have a negative impact on the MAb half-life and clearance 
due to the binding to the mannose receptor-bearing cells [17, 22]. However, some 
other reports indicate that high mannose glycosylated MAbs are removed from 
the blood circulation with the same rate as the complex-type glycoforms [17, 23].  
Some other, less frequently used, cell lines are mammalian (human), avian, 
insect, yeasts, bacteria or plant derived; and some of them have limited abilities 
to glycosylate proteins or they produce glycosylation patterns alternative to 
humans that can be problematic [16]. It is believed that human cell cultures 
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which could solve the problems related to glycosylation will gain more 
popularity in the future. A rapidly developing area is also glycoengineering 
where cell cultures and organisms are genetically manipulated to exhibit 
controlled expression of enzymes involved in glycosylation, producing proteins 
with specific and/or more uniform glycan profile [16, 24]. 
Glycosylation in the Fc region of MAbs also plays an important role in their 
activity and potency. MAbs used in treatment of various cancers exhibit ADCC 
and CDC which result in the killing and removal of the target cancer cells. As 
previously discussed, polyclonal human IgGs and therapeutic MAbs expressed 
in CHO and murine cell lines produce high level of core-fucosylated glycans. 
Recently it has been reported that ADCC activity of the MAbs dramatically 
increased for the MAbs with higher degree of defucosylation and it is expected 
that in the future cell lines with knocked out gene for α-1,6-fucosyltranferase will 
be used for production of highly potent anti-tumour MAbs [25, 26]. On the other 
hand, a higher degree of sialylation in the Fc region of IgGs leads to increased 
anti-inflammatory activity which will direct the future design of therapeutics for 
treatment of inflammatory diseases, such as rheumatoid arthritis [27]. In order to 
understand complex structure-function relationships of glycans, multiple 
approaches to glycomics have to be integrated, including functional genetics that 
provides information on glycan diversification and glycosylation of proteins in 
relation to phenotype; analysis of glycan-protein interactions, development of 
glyco-gene microarrays, glycosylation analysis and bioinformatics [28]. 
In glycan profiling of recombinant glycoproteins, several questions must be 
addressed, such as glycan occupancy, presence of high mannose glycans and 
glycans containing sialic acids, degree of core-fucosylation and presence of 
intersecting GlcNAc. Glycosylation analysis can be performed on the level of 
glycoprotein, glycopeptides or glycans and the choice of the analytical strategy 
will depend on the question to be answered. Different approaches and strategies 
in glycosylation analysis of MAbs will be described.  
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1.2. Analysis of intact and reduced MAbs 
Analysis of intact and reduced MAbs are described also as a “top-down” 
approach and provides information on glycan occupancy and the main 
glycosylation patterns. The simple method for evaluation of glycan occupancy 
employs capillary sodium dodecyl sulfate (SDS) gel electrophoresis coupled with 
UV detection. The non-glycosylated and glycosylated heavy chains of the protein 
can be efficiently separated and the method allows quantitative determination of 
both forms [29].  
Another approach for analysis of intact MAbs employs reversed-phase (RP) 
HPLC coupled with high resolution MS. Separation of glycoforms by RP-HPLC 
is not possible; however, mass spectra contain information about glycan 
heterogeneity. Since deconvoluted mass spectra of intact MAbs can be difficult to 
interpret [30, 31], better differentiation between major glycoforms can be 
achieved after the reduction of MAbs and the separation of light and heavy 
chains by RP-HPLC due to the improved mass resolution and mass accuracy [30]. 
Several less common approaches using enzymes that cleave MAbs in the hinge 
region and analysis of MAb fragments have also been described and they have 
been recently summarised [32].  Although these methods are especially useful for 
fast analysis in production and formulation of MAbs, more detailed analysis on 
glycopeptide and glycan level is required to obtain a complete glycan profile of 
products for therapeutic use.   
1.3. Analysis of glycopeptides 
Analysis of glycopeptides is known also as glycosylation site-specific analysis 
and it is particularly useful in the field of glycomics and understanding of 
glycoproteins on a molecular level, where information about glycan 
heterogeneity as well as the glycosylation site are required. This analytical 
approach is also applicable to recombinant MAbs since it enables high-
throughput characterisation of glycosylation [33]. Due to the method automation, 
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analysis of glycopeptides from human serum IgGs can also be used for screening 
and monitoring of pathological states [34].  Glycopeptides can be obtained by 
enzymatic cleavage commonly using trypsin, lysylendopeptidase (endo-Lys-C) 
or pronase [32, 35]. The size and complexity of peptides and glycopeptides 
formed depend on enzyme specificity. Trypsin digests often contain larger non-
glycosylated peptides which reduce the ionisation efficiency of glycopeptides 
resulting in the suppression of the MS signal. On the other hand, pronase is a 
mixture of endo- and exopeptidases and the products of the enzyme digestion 
are complex mixtures of short peptides and glycopeptides [35]. Prior to MS 
detection, purification and enrichment steps are usually employed, which 
include RP-HPLC, hydrophilic interaction liquid chromatography (HILIC), lectin 
affinity and size-exclusion chromatography, which have been reviewed 
elsewhere [32, 35, 36].  Separation of glycosylated from non-glycosylated 
peptides can be achieved prior or during the LC-MS run. Glycopeptides can be 
differentiated from the non-glycosylated peptides by a specific ionisation pattern 
in collision-induced dissociation (CID) mass spectra, resulting in low molecular 
mass ions such as [Hex+H]+, [HexNAc+H]+, [HexHexNAc+H]+ and [NeuAc+H]+. 
Alternatively, glycopeptides can be screened for specific fragments or neutral 
losses [32, 35]. When the separation of glycopeptides is performed by RP-HPLC, 
the glycopeptides with the same peptide chain are eluted closely together [37]. In 
some other case, the higher retention of glycopeptides containing acidic glycans 
compared to neutral glycans was observed [34].  Enhanced selectivity for 
separation of glycopeptides with the same amino acid sequence and different 
glycan structural isomers was achieved when zwitterionic-type HILIC (ZIC-
HILIC) was used [38].  
1.4. Glycans analysis 
The most widely used approach for glycan profiling of MAbs is a “bottom-up” 
approach, where glycans released from the protein are separated by capillary 
electrophoresis (CE) or LC and detected by MS or fluorescence detection.  
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1.4.1. Sample preparation 
Glycans are most commonly released from MAbs using Peptide: N-Glycosidase F 
(PNGase F). Due to accessibility of the glycosylation site, glycan cleavage in the 
Fc region of IgGs does not require prior denaturation with detergents or 
reducing agents or treatment with proteases. To increase the yields and 
accelerate the reaction, the use of monolithic supports for immobilization of 
PNGase F for glycoprotein digestion was demonstrated [39]. The enzyme 
reactors can be effectively coupled into a multidimensional system which could 
significantly simplify the procedure [40].  Recently, an integrated microfluidic 
device has been developed that was able to perform release of N-linked glycans 
by PNGase F, protein removal and glycan LC separation and it was coupled to 
nano electrospray ionisation (ESI)-MS. The sample preparation and analysis time 
was reduced to 10 min and the protocol was automated [41].  
In special cases, such as MAbs expressed in plant systems with specific 
glycosylation patterns, PNGase A may be used as an alternative [32]. 
Hydrozinolysis is a less suitable method for releasing glycans from MAbs due to 
N-deacetylation and N-deglycolylation and therefore loss of information 
regarding sialylation [42]. Glycans can be analysed in native, reduced, 
permethylated or fluorescently-labelled forms. The choice of glycan 
derivatization is determined by the chosen separation and detection methods.  
Prior to fluorescent labelling, glycan samples should be purified from proteins, 
salts and detergents. 
Glycans are generally labelled for detection by reductive amination via a Schiff 
base in the presence of an excess quantity of an appropriate tag (Figure 1–3) [43]. 
The choice of the fluorescent tag depends on the analytical approach. Labelling 
with a fluorescent tag enables fluorescence detection of glycans with high 
sensitivity (picomole level) as well as MS detection with higher sensitivity 
compared to native glycans, since the introduction of functional groups into the 
molecule increases ionisation efficiency.  The yield of derivatization depends on 
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the first sugar at the reducing end of the glycan. For enzymatically released N-
glycans with GlcNAc at the reducing end, the reaction might be incomplete [44]. 
The most commonly used labels are 2-aminobenzamide (2-AB) and 2-anthranilic 
acid (2-AA) [45]. The procedure was proposed by Bigge et al. [43] 15 years ago 
and since then it has been standardised and commercial kits for quantitative 
labelling of glycans are available.  
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Figure 1–3: Reductive amination of glycans with 2-AB as proposed by Bigge et al. [43]. 
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2-AB glycans are most frequently separated by HILIC with stationary phases 
having an amide functionality and databases for identification of glycans based 
on retention properties have been established [46]. One of the early introduced 
fluorescent tags was 2-aminopyridine (2-AP); however, non-quantitative yields 
and lower sensitivity are generally obtained [45]. Advances in fluorescent 
derivatization of glycans were reviewed by Anumula [45]. 
Detailed structural characterization of glycan species usually requires MS in 
combination with digestion by exoglycosidases which release a specific 
monosaccharide residue at the non-reducing terminus. Additional information 
about linkages and branching can be obtained where MS and tandem MS data 
are not sufficient for elucidation of glycan structures. Commonly used enzymes 
include α-galactosidase, β-galactosidase, α-mannosidase, α-sialidase, β-N-
acetyhexosaminidase and α-L-fucosidase from various sources (Figure 1–4), and 
they can be used sequentially or as an array of exoglycosidase mixtures  [47]. 
While the enzymatic sequencing is tedious, the parallel enzyme analysis is 
considerably shorter. Glycans are commonly labelled via reductive amination 
prior to the exoglycosidase digestion and separation [47, 48]. Another popular 
approach used for structural elucidation includes analysis of glycans in 
permethylated form without prior separation by matrix-assisted laser desorption 
ionisation (MALDI)-MS [49, 50] which will be further discussed below. 
Exoglycosidase digestions have been optimised for direct coupling with MALDI-
MS to simplify the procedures, save time and increase throughput. Instead of 
classic sodium phosphate buffers, MS-friendly (i.e. volatile) ammonium acetate 
and ammonium formate buffers can be used [49, 51] and the digestion can be 
performed directly on the MALDI target [52, 53]. Similar strategies can be 
applied to analysis of glycoproteins from natural sources where glycosylation 
patterns have not been previously examined [54, 55]. 
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Figure 1–4: Schematic representation of exoglycosidases digestions with the most 
common exoglycosidases used for the cleavage of specific linkages.   
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1.4.2. Capillary electrophoresis  
The most attractive feature of capillary electrophoresis (CE) analysis of glycans 
compared to HPLC approaches is reduced time of separation. However, CE 
analysis of glycans generally requires derivatization of oligosaccharides to 
introduce the charged group needed for migration in an electric field, to increase 
sensitivity by laser-induced fluorescence (LIF) detection, and to improve 
ionisation efficiency in MS. As an exception, sialylated glycans can be analysed 
by CE in the native form, since they can be easily deprotonated [56]. The 
electrophoretic mobility depends on the charge and the size of the glycan. 
Charged fluorescent tags, such as 2-aminobenzoic acid (2-AA) [29] and 8-
aminopyrene-1,3,6-trisulfonate (APTS) [57, 58], are most often used. Since APTS 
carries 3 negative charges, APTS-labelled glycans can be analysed with high 
speed and resolution and major glycans found in MAbs can be analysed in less 
than 10 min [57, 59, 60]. Due to faster migrating rates and overlapping with 
reagent-derived peaks, some difficulties analysing minor species, sialic acids and 
high mannose glycans, have been reported [61]. The CE separation of APTS-
labelled glycans was further developed for more detailed analysis of minor 
glycans, such as sialic acids and defucosylated species, and adapted for on-line 
coupling with MS [58]. Since 2-AA has a single negative charge, the CE-LIF 
analysis time is longer compared to analysis of APTS-labelled glycans. However, 
the 2-AA reagent is less expensive and easily commercially available, and 
collected 2-AA derivatives can be further analysed by LC-MS for further 
structural characterisation. CE analysis of MAbs and glycoproteins has recently 
been reviewed [44, 61]. 
1.4.3. Ion-exchange chromatography 
Since glycans form anions at high pH, they are suitable for separation by high pH 
anion-exchange chromatography (AEC). The presence of redox-active functional 
groups makes glycans suitable analytes for pulsed amperometric detection 
(HPAEC-PAD) and low picomolar sensitivity can be achieved on analytical 
Chapter One  Literature review 
- 16 - 
 
columns [62]. Since high salt eluents are used in HPAEC, structure elucidation by 
MS requires off-line desalting. The demands for complex and detailed structural 
analysis require on-line coupling of HPAEC with mass spectrometry and an 
approach including on-line desalting was suggested [63]. HPAEC-PAD has been 
shown to be suitable for monitoring batch-to-batch variability of MAb 
glycosylation with simultaneous analysis of neutral and sialylated glycans [64].   
Anion-exchange chromatography has recently been used as a part of 2D HILIC 
system where neutral and charged AP-glycans were sequentially eluted, based 
on the number of charged residues, and detected by fluorescence [65]. Although 
the progress in separation of glycans using AEC continues, the technique has not 
gained the same level of popularity as HILIC or use of graphitized carbon 
columns.  
1.4.4. Hydrophilic interaction liquid chromatography (HILIC) 
Almost all HILIC stationary phases used for the separation of glycans are silica 
based with non-ionic (amide, diol) or ionic (amine, aminopropyl and 
zwitterionic) functionalities. Due to instability in aqueous solvents, adsorption or 
reactivity with analytes, bare silica, aminopropyl and amine columns tend to be 
less suitable for glycan separations [66]. In most of the recent publications use of 
amide and zwitterionic (ZIC-HILIC) columns is described. Glycans are retained 
on HILIC stationary phases in native, reduced or fluorescently-labelled forms. 
The interaction with HILIC stationary phases generally increases with increasing 
size of the glycan. One of the early strategies included separation of 2-AB 
labelled glycans using a silica-based stationary phase with amide functionality, 
coupled with fluorescence detection [67]. The method was shown to be suitable 
for analysis of neutral and sialylated glycans in a single run, providing 
information on their correct molar proportions. A dextran ladder was used to 
determine the elution positions of standard glycans in glucose units and 
incremental values for addition of monosaccharide residues to the glycan core 
were calculated. This information was used for interpretation of glycan profiles; 
and the glycans were confirmed with sequential exoglycosidase digestions [67]. 
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Although this approach has been standardised, it is complex and time-
consuming. A large effort has been put into increasing the sample throughput 
and simplifying the data analysis [68]. A database of 2-AB labelled glycan 
structures with retention times expressed as glucose units has been established, 
which shows the correlation between the retention properties and glycan 
composition, monosaccharide sequence and linkages [46]. The same research 
group developed an autoGU tool linked to the GlycoBase, which automatically 
assigns possible glycan structures to each HPLC peak [46].  On the other hand, 
coupling of HILIC separations with MS might simplify the procedure and 
provide more direct information about glycan composition. An ultra-high 
performance liquid chromatography (UHPLC) HILIC column packed with sub 2 
µm amide sorbent has recently been used for separation of 2-AB labelled N-
glycans and faster analysis with improved resolution compared to standard 
packing material. The UHPLC column was used for identification of cancer 
associated alterations in serum glycosylation and correlation between branching, 
sialylation and galactosylation of serum proteins and progress of the stomach 
adenocarcinoma was confirmed [69].   
An amide HILIC method using optimized sample preparation of 2-AB labelled 
glycans has recently been evaluated for analysis of N-glycans from recombinant 
pharmaceuticals. It was demonstrated that the procedure is in accordance with 
regulatory requirements of the biotechnology industry [70]. 
The amide HILIC method has also been widely used for the separation of glycans 
derivatized with 2-aminobenzoic acid (2-AA). The intensity in fluorescence 
detection is approximately twice as high compared to 2-AB and the reaction can 
be performed in aqueous medium [71], which makes the label particularly 
attractive for high-throughput glycosylation analysis [72]. Recently, it has been 
shown that structural isomers varying in linkage of core fucose can be effectively 
separated using this method and the structures were confirmed using MALDI 
TOF/TOF tandem mass spectrometry. A distinctive ion found in CID 
fragmentation spectra of 2-AA glycans confirmed the presence of allergenic 3-
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linked core fucose found in insect and plant glycoproteins. On the other hand, 
MS/MS analysis of 2-AB labelled glycans did not provide the information on the 
linkage position [73]. The results indicate that the choice of an appropriate 
derivatizing agent may provide additional information when coupled to MS/MS.   
A similar strategy as described for amide HILIC has recently been used for the 
separation of 2-AA and 2-AB labelled glycans in mixed mode, combining HILIC 
and anion-exchange chromatographic mechanisms, and it was termed 
hydrophilic interaction anion-exchange chromatography (HIAX). The idea is not 
new [71]; however, the proposed method allowed the use of an external standard 
to generate GU values for eluted glycans across the entire separation range. 
Using this it was possible to distinguish neutral from charged species in a single 
chromatographic run, which was an improvement compared to the generally 
used HILIC mode [74].  
The need for fluorescent labelling can be successfully overcome by downscaling 
to capillary and nano formats. The amide HILIC method (using a 75 µm I.D. 
column) was shown to separate underivatized N-glycans at low-femtomole 
sensitivity when coupled to ESI-MS. Since nano LC systems may exhibit run-to-
run variations in elution times, co-chromatography of a dextran ladder may be 
required to standardise retention times [75]. Nanoscale amide HILIC has recently 
been coupled to the high resolution Orbitrap mass spectrometer. The method 
was applied to glycosylation analysis of plasma glycoproteins from healthy 
controls and cancer patients and two glycans with potential diagnostic value 
were identified [76]. A similar study was performed using micro amide HILIC 
[77]. These data suggest that improved sensitivity mainly due to the lower 
chromatographic dilution in miniaturised HILIC systems may be sufficient for 
glycan profiling without the need for time-consuming and expensive 
derivatization with fluorescent tags. 
Another widely used stationary phase in glycosylation analysis is zwitterionic-
type HILIC (ZIC®-HILIC, Merck SeQuant) with sulfobetaine functional groups. 
ZIC-HILIC has been used primarily for the separation or enrichment of 
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glycopeptides [78-80]; however, it has been demonstrated that ZIC-HILIC is also 
suitable for the separation of AP-labelled glycans and the column exhibited an 
enhanced capability of structural recognition [38, 80]. Our group recently 
reported the use of ZIC-HILIC stationary phase for separation of reduced glycans 
from monoclonal antibodies [81].  
Both ZIC-HILIC and amide columns have been successfully coupled into 2D 
systems with anion-exchange chromatography [65], which shows the potential 
for improving chromatographic resolution in glycosylation analysis of complex 
samples. 
1.4.5. Graphitized carbon liquid chromatography 
Porous graphitized carbon (PGC) has been shown to be a suitable stationary 
phase for separation of glycans from glycoproteins, either from natural sources 
[82-84] or produced by recombinant technology [37, 85].  Due to the high 
selectivity of PGC columns for separation of anomers, most of the separations are 
performed on reduced glycans, coupled with MS.  The main advantage of PGC 
lies in the separation of underivatized glycans, although the method is also 
compatible with permethylated and fluorescently-labelled glycan forms, recently 
summarised by Ruhaak et al. [86]. PGC exhibits superior capability for the 
separation of structural and linkage isomers of high mannose [82] and complex 
glycans, with various degrees of sialylation [83] and sulfation [85]. Unlike for 
amide HILIC, currently no databases of retention properties of glycans on 
graphitized carbon are publicly available. However, a useful approach which 
included biosynthesis of all possible glycan mono- and disialylated glycan 
structures using recombinant transferases and establishment of a retention time 
library has been demonstrated [83]. Using this approach a detailed structural 
analysis of charged N-glycans from various mammalian sources was performed. 
It has to be noted that neutral and acidic glycans exhibit significantly different 
behaviour on graphitized carbon, therefore solvent, temperature and ion polarity 
have to be chosen accordingly [87].  Sensitivity in glycosylation analysis by PGC 
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was improved when the system was downscaled to nanoscale format columns 
and low femtomole quantities of oligosaccharides were detected by ion-trap MS 
[88]. Nanoscale separation has also been performed by graphitized carbon 
microchips and coupled with high resolution TOF-MS, which enabled sensitive 
analysis of glycans from human serum and identification of structures based on 
high mass accuracy spectra [89].  For the analysis of isobaric structures and 
studies of linkages, LC techniques exhibit a clear advantage over tandem MS 
approaches and the development will most certainly continue in both directions.   
1.4.6. Reversed phase chromatography 
Reversed-phase chromatography of oligosaccharides is considered to exhibit 
orthogonal selectivity to HILIC and the combination of both approaches is 
commonly used for method evaluation. Glycans generally require derivatization 
to achieve retention on the RP stationary phases. Labels widely compatible with 
HILIC, such as 2-AB [90, 91], 2-AP [92] and 2-aminoacridone [93], are generally 
used in RP analysis of glycans. Analysis of fluorescently-labelled glycans by 
HILIC and RP, usually in combination with exoglycosidase digestions, is also 
called 2D chromatography or 2D-mapping [65, 93]. In the case of sialic acids 3D 
mapping can be employed, with additional separation by anion-exchange 
chromatography [94]. This approach provides more detailed information 
compared to the one-dimensional approach; however, it is extremely tedious and 
therefore is not suitable for routine analysis in glycomics research or quality 
control of pharmaceuticals. In HILIC, peaks for N-glycans from different classes 
can overlap, which can be an issue when separation is coupled to fluorescence 
detection. In contrast, in RP separation N-glycans from different classes are 
segregated in defined regions of the chromatogram which enables simpler and 
more accurate quantification [90]. The RP separation of 2-AB labelled N-glycans 
into classes, sialylated, high mannose, defucosylated complex, tri- and 
tetraantennary complex, and biantennary complex, has been demonstrated and 
the method was successfully applied to recombinant antibodies [90]. A high-
throughput RP protocol for glycosylation analysis of recombinant glycoproteins, 
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involving microwave-assisted deglycosylation and labelling with 2-AB has also 
been recently proposed [91]. 
Another derivatization procedure for increasing glycan hydrophobicity and 
thereby allowing RP separation is permethylation. Permethylation was 
established by Ciucanu and Kerek [95] and it has become extensively used in 
combination with tandem MS due to the predictable and highly informative 
fragmentation of permethylated glycans. Permethylation was shown to be 
compatible with RP on its own or with additional derivatization of glycans with 
a fluorescent tag [96].   
Human Proteome Organisation (HUPO) Human Disease Glycomics/Proteome 
Initiative (HGPI) conducted a study in collaboration with 20 laboratories, where 
various chromatographic and MS techniques were evaluated in order to establish 
technical standards for this complex type of analysis. The N-glycan analysis of 
the same transferrin and IgG samples performed using chromatography of 2-AB, 
2-AA and 2-AP labelled glycans yielded good quantification. Graphitized carbon 
separation of reduced glycans coupled with ESI-MS in negative ion mode also 
provided acceptable quantification. The results indicate that both fluorescence 
and MS-based analysis is suitable for identification and quantification in 
glycomic studies [97].  
1.4.7. Analysis of glycans by mass spectrometry 
In glycomics, commonly used techniques are MALDI and ESI which allow 
ionisation of non-volatile substances and are applicable to glycoproteins, 
glycopeptides and glycans, all of which can be detected at extremely low levels 
(femtomoles-picomoles) depending on the sample conditions [98].  
1.4.7.1. MALDI-MS and ESI-MS in glycosylation analysis 
MALDI was developed primarily for the analysis of macromolecules; however, 
the method became widely applicable to smaller molecules as well. In a MALDI 
experiment, the sample is mixed with an excess of a low molecular weight UV-
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absorbing matrix which absorbs energy from a laser pulse and the energy is 
transformed from matrix to the sample. The energy transfer results in desorption 
of matrix and analyte from the surface and formation of ions in the gas phase. 
The ions are then electrostatically directed into a mass analyser [98]. MALDI is 
most commonly coupled with TOF mass analysers which can analyse ions with 
very high m/z. Higher resolution can be achieved when quadrupole orthogonal 
acceleration time-of-flight analysers (QTOF) are used. MALDI is a soft ionisation 
technique and fragmentation of oligosaccharides is usually low.  
Electrospray is also a soft ionisation technique and it is suitable for analysis of a 
wide range of biomolecules. In principle, an electrolyte-containing analyte 
solution is pumped through a metal capillary, which is held at high potential. 
Due to the high electric field, a mist of highly charged droplets is generated. Dry 
gas and heat are applied to evaporate the solvent. As the droplet size decreases to 
the extent that surface-coulombic forces overcome surface-tension forces, the 
droplet breaks up to smaller droplets and the process continues until an ion 
desorbs from a droplet or solvent is completely removed. The beam of ions is 
then directed into a mass analyser through a series of lenses [98]. ESI-MS is 
ideally coupled to separation techniques, such as HPLC, and is usually combined 
with tandem mass analysers. Fragmentation is generally low and it can be 
produced by CID where a parent ion is selected by the first mass analyser and 
the fragment ions are analysed in the second mass analyser. The commonly used 
analysers are ion traps, triple quadrupole and QTOF instruments.  
1.4.7.2. Glycan fragmentation    
Fragmentation of glycans has been studied in fast atom bombardment (FAB)-MS, 
MALDI-MS and ESI-MS, either for native or derivatized glycans. Similar 
fragments are observed with all the techniques and they largely depend on the 
applied energy, type and the nature of the adduct, and lifetime of the ion before 
reaching the detector [99, 100]. Two major types of cleavages are reported, 
glycosidic cleavage and cross-ring cleavage (Figure 1–5). The glycosidic cleavage 
occurs between two rings, whereas the cross-ring cleavage results from breaking 
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two bonds on the same sugar residue [99]. Glycosidic cleavages predominate and 
give information on sequence and branching whereas the cross-ring cleavages 
provide information on linkages [100]. The degree of fragmentation depends 
strongly on the ion; the protonated species exhibit higher fragmentation than 
alkali metal coordinated oligosaccharides [101, 102].  
Fragmentation can be performed in positive or negative ion mode and both 
methods provide complementary information. CID fragmentation of positive 
ions of underivatized N-glycans ionized by ESI showed that more energy was 
needed to fragment [M+Na]+ ions than [M+H]+ [100]. The protonated ions 
exhibited mainly glycosidic cleavage with main B- and Y-type fragments (Figure 
1–6), whereas sodium adducts gave more complicated and informative spectra, 
also with cross-ring cleavages. The most abundant fragments resulted from loss 
of the terminal GlcNAc. Other prominent fragments were products of successive 
additional losses of residues at the non-reducing terminus [100]. CID spectra of 
oligosaccharides ionized by MALDI showed an additional effect of the matrix on 
fragmentation. While α-cyano-hydroxycinnamic acid (CHCA) promoted the 
glycosidic cleavages, the 2,5-dihydroxybenzoic acid (DHB) promoted also cross-
ring cleavages and formation of “internal” cleavage ions, derived from 
elimination of substituents from around the pyranose ring [103]. Also 
fragmentation of glycans derivatized with some common labels has been 
extensively studied. The CID fragmentation mass spectra of 2-AB labelled glycan 
sodium adducts provided rich information on glycan composition and sequence 
due to the dominating glycosidic cleavage [104].  As previously mentioned, 
additional linkage information was obtained from CID glycan spectra when 2-
AA tags were used instead of 2-AB [73]. Another advantage of 2-AA over 2-AB is 
improved sensitivity in negative ion mode, which makes the 2-AA label suitable 
for analysis of minor species [105]. Recently, a method using a stable isotopic 2-
AA tag for rapid direct infusion MS has been reported. Introduction of a stable 
isotopic tag at the reducing end alleviates the isomeric complexity and allows the 
segregation between the isomeric reducing and non-reducing end fragment ions 
[106].  
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Figure 1–5: Types of carbohydrate fragmentation as proposed by Domon and Costello [99]. 
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Figure 1–6: Glycosidic bond cleavage-formation of B- and Y-ions adapted from Domon and Costello [99]. 
Chapter  One                           Literature review 
- 26 - 
 
Higher quality MS/MS spectra of sodiated adducts compared to protonated 
species is not the only reason why fragmentation of protonated adducts is 
generally avoided. It has been reported that fragmentation of protonated N-
glycans with fucosylated antennae can lead to migration of fucose between the 
antennae and it can result in misleading fragments. It was suggested that fucose 
rearrangements are the result of the decomposition and similar spectra were 
obtained when ion trap and TOF/TOF mass analysers with very different 
lifetimes of the ions were used. The same pattern was observed for native and 2-
AB labelled glycans; however, the fucose migration was not observed for 
permethylated glycans [107]. The rearrangement reactions are also known as 
internal residue loss and have been reported also for hexose residues in high 
mannose and biantennary complex glycans, either in glycopeptide or reductively 
aminated forms [108]. 
When the negative ion mode is used, oligosaccharides readily form [M-H]- ions 
and the corresponding fragments. In the presence of various anions, such as  
SO42-, Cl-, Br-, I- and NO3- [109-112], stable anion adducts are formed that are 
transmitted into the collision cell where they form identical fragment ions to 
those that originate from [M-H]- ion, indicating the similar fragmentation 
mechanism [109]. CID spectra of [M-H]- ions and negative adducts generates C-
type glycosidic and cross-ring fragmentation, which provides additional 
information on linkage position. On the other hand, the positive ion mode results 
mainly in B- and Y-type fragmentations, which are less informative regarding the 
structure [109, 110, 113]. Fragmentation of negative ions has been studied for 
glycans in various forms, such as native or 2-AB labelled.  
The most widely used approach in tandem MS of glycans includes 
permethylation and there are several advantages of performing this additional 
derivatization step, either on native or labelled glycans. Fragment spectra of 
permethylated glycans are usually more informative, containing extensive cross-
ring cleavages, providing details on branching and linkages. An additional 
advantage of permethylation is stabilization of sialylated glycans which in the 
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underivatized form easily fragment with the loss of sialic acid. At the same time, 
permethylation neutralizes negative charges and thus makes the sialylated 
glycans suitable for analysis in the positive ion mode where higher sensitivity is 
generally achieved [114]. In the same study it was demonstrated that the specific 
cross-ring fragments allow distinction between α2-3 and α2-6 linkages of sialic 
acid residues. Since permethylation can cause degradation of sialic acids, an 
alternative approach without derivatization using the negative ion mode 
fragmentation has also been suggested. It has been shown that permethylation is 
not necessarily required to distinguish between α2-3 and α2-6 linkages of sialic 
acid residues [115]. 
There has still been a lot of discussion whether MS is suitable for quantitative 
analysis due to the different ionisation efficiencies for charged and neutral 
glycans and in-source decomposition of sialic acids. The standard approach for 
analysis of glycans includes permethylation; however, the harsh conditions used 
in the procedure can cause partial hydrolysis of sialic acids and is therefore not 
recommended for quantification of acidic glycans. Several alternative 
derivatization procedures have been suggested, including methyl esterification 
and amidation of carboxyl groups. The first method is based on neutralisation of 
negatively charged groups by methyl esterification without oxidative 
degradation, followed by derivatization with Girard’s reagent T to introduce 
permanent charge into the molecule. The final product of the reaction gives a 
simple MS spectrum without additional metal adducts. The quantification of 
sialic acids by the new method was demonstrated on recombinant therapeutic 
glycoprotein expressed in two CHO cell lines, giving significantly different 
glycan profiles [116]. 
Another approach for quantitative analysis of N-glycans included amidation of 
acidic glycans, PNGase F digestion, and desalting, using a single-pot approach 
enabling high-throughput analysis. The new method was based on amidation of 
sialic acids under mild acidic conditions while the glycan was still attached to the 
protein. Release of neutral glycans followed by derivatization at the reducing 
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end resulted in the final products with permanent charges that could be 
quantitatively analysed by MALDI-TOF [117]. 
Since correlation between breast cancer and changed ratio of α2-3 and α2-6 
linkages of sialic acid has been observed, a MS method has been developed that 
enables observing differences in the ratio between the two in healthy and 
diseased populations. The method is based on selective amidation of α2-6 linked 
sialic acids; while α2-3 linked undergo spontaneous lactonization. The glycans 
are subsequently permethylated and analysed by a MALDI-TOF-MS analysis 
[118]. 
When it comes to analysis of structural isomers, sequential mass spectrometry 
(MSn) can be a valuable tool, especially when MS is not coupled to the prior 
separation of glycans. Sequential mass spectra can be interpreted manually; 
however, computational interpretation may be used as an aid and it is believed 
in the future it might be completely automated [119]. The same strategy has been 
applied to recognizing and studying differences in metastatic and non-metastatic 
tumour cells, which demonstrates the potential use of this approach in glycomics 
studies [120]. Sequential mass spectrometry is useful also in combination with 
LC techniques where separation of glycan isomers might not be achieved [92].   
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Chapter Two 
 2. Hydrophilic interaction liquid chromatography of glycans  
2. 1. Introduction 
Immunoglobulin G (IgG) is the most abundant immunoglobulin and it is 
generally responsible for recognition of pathogens and toxic antigens and their 
subsequent neutralization and elimination through activation of biologic effector 
mechanisms. Monoclonal IgGs represent a rising group of pharmaceuticals and 
their potency, stability and immunogenicity largely depend on their post-
translational modifications, especially N-glycosylation in the conserved domain. 
The N-glycans are generally of biantennary complex type, most of them core-
fucosylated [10] and variations in structure, such as defucosylation and 
sialylation, can have great effect on the biological activity of a product [25, 27]. 
Therefore, the glycan profiling of IgGs of pharmaceutical interest is of high 
importance. However, rapid glycosylation profiling of large numbers of samples 
for quality control and clone selection remains a challenge [32]. 
Standard procedures for glycan analysis include in-solution digestion of 
glycoprotein samples with PNGase F, thus releasing the glycans from the 
glycoprotein. Following this step, the most common strategy for analysing 
enzymatically-released glycans from antibodies and glycoproteins generally 
includes labelling at the reducing end of oligosaccharides followed, by liquid 
chromatography (LC), combined with either fluorescence or MS detection. 
Labelling of glycans for fluorescence detection is most commonly achieved via 
reductive amination with aromatic amines, such as 2-aminobenzamide (2-AB), 2-
anthranilic acid (2-AA) or 2-aminopyridine (AP) [43, 45]. As well as enabling 
fluorescence detection, pre-column derivatization, such as fluorescent labelling 
or permethylation, is also usually required to improve chromatographic 
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resolution, sensitivity in ESI-MS and formation of fragment ions which provide 
additional structural information [66, 121].  
Separations of oligosaccharides derived from glycoproteins have been achieved 
using a range of stationary phases including reversed-phase (RP), HILIC and 
graphitized carbon, each coupled with MS or fluorescence detection [32]. The use 
of graphitized carbon columns has recently been shown to be very promising for 
glycan analysis, showing improved performance in the separation of isomeric 
oligosaccharides, usually in the reduced or fluorescently-labelled form [37, 82]. 
These methods mostly use MS, rather than fluorescence detection.  A minor 
disadvantage of this approach is that the use of graphitized carbon columns for 
reducing glycans usually results in an undesirable separation of anomers.  
A widely used method for analysis of protein glycosylation is HILIC using TSK 
amide-80 columns (Tosoh biosciences) in combination with fluorescence 
detection of 2-AB labelled glycans. Acetonitrile-water gradients with volatile 
buffers are used for elution, which makes the method compatible with MS. In 
general, the retention of oligosaccharides increases with the increasing number 
of sugar residues and a dextran ladder which enables measuring retention 
relative to glucose units is commonly used for identification of oligosaccharides. 
Improved sensitivity can be achieved by down-scaling to a 75 µm internal 
diameter TSK Amide-80 column and coupling on-line with nano-ESI-MS [75]. As 
nano LC systems often exhibit poor reproducibility in retention times, co-
chromatography of a 2-AB labelled glycan ladder and 2-AB labelled samples 
may be required using this approach [75]. Alternatively, HILIC amide columns 
can also be used for the separation of unlabelled glycans [77], although this 
approach is less common.  
Recently, as an alternative to amide HILIC columns, the use of ZIC-HILIC 
columns with sulfobetaine groups has been reported for the separation of 
sialylated AP-derivatized N-glycans and N-glycopeptides [38, 80]. These 
columns have been shown to be capable of structural recognition and allow 
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better separation of AP-glycan structural isomers compared to amide columns 
[32]. 
Since MALDI-MS and ESI-MS commonly do not fragment oligosaccharides, they 
are the most suitable approaches for the MS analysis of complex mixtures of 
glycans. Native neutral glycans are commonly detected with the best sensitivity 
in the positive ion mode and sialylated glycans are best detected in the negative 
ion mode [98]. The 2-AB labelled oligosaccharides are usually detected in the 
positive ion mode as sodium adducts [98], although detection in the negative ion 
mode has some advantages, such as higher stability of fucose linkages and 
various possible cross-ring fragmentations which give additional structural 
information [113].  
In this chapter, the use of a ZIC-HILIC column for the simple analysis of 2-AB 
labelled, native and reduced glycans from monoclonal antibodies is 
demonstrated. These new methods have been compared to a standard method 
commonly used in the pharmaceutical industry. Using a ZIC-HILIC column 
demonstrates several advantages and is shown to have the capability of 
structural recognition of reduced oligosaccharides, a feature that is similar to 
graphitized carbon columns. 
2.2. Materials and methods 
2.2.1. Reagents and chemicals 
Unless otherwise noted, all chemicals were of analytical grade. Acetonitrile was 
obtained from VWR International (Poole, UK). Acetic acid, ethanol, 2-
aminobenzamide labelling kit, ribonuclease B (R7884), sodium borohydride, 
mannose 3 glycan, mannose 9 glycan, maltopentaose, maltohexaose and 
maltoheptaose were obtained from Sigma (St. Louis, MO, USA). Formic acid, 
ammonium hydroxide and ammonium bicarbonate were obtained from Fluka 
(Steinheim, Germany). 
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Samples of MAbs prepared by recombinant DNA technology (denoted as MAb1, 
MAb2 and MAb3) were kindly donated by Pfizer Inc. (St. Louis, MO, USA). 
2.2.2. Sample preparation 
Glycoprotein samples were desalted prior to digestion using centrifugal filter 
units (Amicon Ultra, 10.000 MWCO, Millipore, Carrigtwohill, Ireland). Glycans 
were released from glycoproteins (250 µg) by incubation with 3 µL of PNGase F 
(500 units/mL, from Elizabethkingia meningoseptica; Sigma) per 100 µL of 50 
mM ammonium bicarbonate buffer, pH 8.0, overnight at 37 ˚C. Proteins were 
removed by precipitation with 400 µL of ice-cold ethanol. Dried supernatants 
were stored at -20 ˚C for further analysis, labelling with 2-AB or reduction with 
sodium borohydride. 2-AB labelled glycans were prepared by following the 
protocol provided by the manufacturer and reconstituted in 100 µL of water 
prior to analysis. The dried samples were reduced by adding 20 µL of 0.5 M 
sodium borohydride in 50 mM sodium hydroxide and incubating at room 
temperature overnight. The samples were then acidified by adding 5 µL of 
glacial acetic acid and desalted by ion-exchange chromatography (Dowex MR-3 
mixed bed, Sigma). 
2.2.3. Amide HILIC coupled with fluorescence detection 
The glycans released from the MAbs were derivatized with 2-AB to enable 
fluorescence detection. Glycan profiling in HILIC mode with fluorescence 
detection was performed on a Waters 2690 Separation Module equipped with a 
Waters 474 Scanning Fluorescence detector (Waters, Milford, MA, USA). The 
excitation wavelength was set at 330 nm and the emission wavelength at 420 nm. 
The column used was a TSK Gel Amide-80 (4.6 x 250 mm, 5 µm) from TOSOH 
Bioscience (Tokyo, Japan). Eluent A consisted of acetonitrile and Eluent B of 250 
mM ammonium formate, pH 4.4. Eluent flow-rate was 0.4 ml/min and the 
column oven temperature was thermostated to 30 C. Elution was achieved 
using a binary step gradient from 70 to 60% Eluent A from 0-90 min, followed by 
a linear gradient 60 to 5% A from 90-140 min, finally reaching 0% A at 145 min. 
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The eluent composition was thereafter returned to 70% A in 1 min and the 
system re-equilibrated for 14 min. 25 µL of the sample was injected onto the 
column. 
2.2.4. ZIC-HILIC of 2-AB labelled glycans  
The glycans released from the MAbs and the RNase B were derivatized with 2-
AB. Glycan profiling with fluorescence detection was performed on a Waters 
2690 Separation Module equipped with thermostated column compartment and 
a waters 474 Scanning Fluorescence detector (Waters, Milford, MA, USA). The 
excitation wavelength was set at 330 nm and the emission wavelength at 420 nm. 
Separations were performed with SeQuant™ ZIC®-HILIC column (2.1 x 150 
mm, 3.5 µm) from Merck SeQuant (Umeå, Sweden). Eluent A consisted of 
acetonitrile and eluent B from 17 mM acetic acid, pH 3.25. The flow-rate was 0.3 
ml/min and the column oven temperature was thermostated to 30 °C. 2-AB 
glycans were eluted using gradient elution, starting with a 10 min isocratic step 
at 20% B, followed by a linear gradient from 20 to 30% B in 50 min, followed by a 
wash step at 80% B for 5 min. Prior to the next injection, the system was 
equilibrated for 15 min at 80% B. The sample was reconstituted in 100 µL of 
deionised water and 5 µL of the sample was injected onto the column. Glycan 
profiling with ESI-MS detection was performed using a MicrOTOF-Q™ (Bruker 
Daltonik, Bremen, Germany) with an Agilent 1200 series binary pump and 
autosampler (Agilent, Santa Clara, CA, USA) with the column installed in a 
column oven (Thermosphere, TS-130, Phenomenex, USA)  operated at 30 °C. 
Gradient conditions were the same as described for the fluorescence detection. 
The ESI-MS conditions were: capillary voltage, 4.5 kV; drying gas temperature, 
200 ˚C; drying gas flow, 8 L/min; nebulizer pressure, 1.5 bar; scan range m/z 50-
3000.  
2.2.5. ZIC-HILIC of native and reduced glycans  
Experiments were performed using a MicrOTOF-Q™ (Bruker Daltonik, Bremen, 
Germany) with an Agilent 1200 series binary pump and autosampler (Agilent, 
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Santa Clara, CA, USA). Separations of glycans released from RNase B and MAbs 
were performed with SeQuant™ ZIC®-HILIC column (2.1 x 150 mm, 3.5 µm; 
Merck SeQuant, Umeå, Sweden) installed in a column oven (Thermosphere, TS-
130, Phenomenex, USA) at 30 ˚C.  The flow-rate was 0.3 mL/min. Eluent A 
consisted of acetonitrile and eluent B of 34 mM acetic acid, pH 3.0. Native and 
reduced glycans were eluted using gradient elution starting at 90% A, a linear 
gradient 90 to 75% A from 0 to 10 min, followed by a linear gradient 75-70% from 
10 to 80 min and a linear gradient 70-40% A from 80 to 100 min, followed by an 
isocratic step at 40% A for 5 min. At 106 min the eluent composition was 
returned to 90% A and the system equilibrated for 14 min. Separation of linear 
oligosaccharides maltopentaose, maltohexaose and maltoheptaose was 
performed using the same eluents as for RNase B and MAbs glycans. The flow-
rate was set at 0.3 mL/min. Reducing oligosaccharides were eluted using a linear 
gradient 90 to 35% A from 0 to 20 min, followed by an isocratic step at 35% A for 
5 min. At 26 min the eluent composition was returned to 90% A and the system 
equilibrated for 14 min. Acquisition of mass spectra was performed in the 
positive ion mode. The ESI-MS conditions were: capillary voltage, 4.5 kV; drying 
gas temperature, 200 ˚C; drying gas flow, 8 L/min; nebulizer pressure, 1.5 bar; 
scan range m/z 50-3000.  
2.3. Results and discussion 
2.3.1. Separation of 2-AB-glycans using amide HILIC   
One of the most commonly used procedures for the analysis of glycans in the 
pharmaceutical industry is to label glycans with 2-AB followed by separation of 
labelled glycans using a HILIC column with amide functionality, coupled with 
fluorescence detection. Peaks are usually assigned based on the retention times 
of 2-AB labelled standards; however, standards for low abundance glycans are 
not commercially available and collection of fraction with offline MS analysis 
may be required for identification when less common glycan species are present 
in a sample.   
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RNase B and monoclonal antibodies MAb1, MAb2 and MAb3 used in this study 
were digested using the enzyme PNGase F and the released glycans were 
labelled with 2-AB and analysed by the standard procedure, using an Amide-80 
column and fluorescence detection. Glycan profiles obtained by this standard 
procedure were used for comparison with the new methods for analysis of 2-AB 
labelled, native and reduced glycans separated on the ZIC-HILIC column 
coupled with fluorescence and ESI-MS.  
 
 
Figure 2–1: Separations achieved on an Amide-80 column with fluorescence detection of 
2-AB labelled glycans released from RNase B. Man5-Man9 glycans were identified; the 
retention time increases with the increasing molecular weight of glycans. Man7 structural 
isomers were partially separated. Gradient elution: mobile phase A-acetonitrile; mobile 
phase B-250 mM ammonium formate, pH 4.4. 
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Table 2-1: Relative quantification of high mannose glycans from RNase B obtained by 
Amide-80 column coupled with fluorescence detection. 
Structure Abbr. 
Retention time 
[min] 
Relative 
peak area 
[%] 
 
Man5 64.8 37.4 
 
Man6 77.4 28.0 
 
Man7 
84.5 
86.2 
89.4 
2.3 
4.4 
5.0 
 
Man8 100.5 16.6 
 
Man9 104.7 6.3 
      GlcNAc;  mannose 
 
RNase B is a relatively simple and well-studied glycoprotein, which contains 
high mannose oligosaccharides with 5 to 9 mannose residues. Peaks in the 
fluorescence chromatogram of RNase B glycans can be assigned based on the 
general rule in HILIC that elution time increases with the size of the glycan. As 
illustrated in Figure 2–1, between 75 and 84 min a cluster of partially separated 
peaks can be observed, which most likely correspond to partial separation of 
Man7 structural isomers. As expected, all glycans Man5 to Man9 were found in 
the RNase B glycan profile, with relative % areas summarised in Table 2-1. 
Figure 2–2 shows glycan profiles of the different MAbs studied in this work, 
obtained by the standard procedure. The observed glycosylation patterns are 
consistent with glycosylation expected in mammalian expression systems, 
containing mainly fucosylated biantennary complex glycans, G0 (45.6-84.8% 
relative area), G1 (11.3-33.4%), G0-GlcNAc (2.4-3.1%) and G2 (0.7-5%).  
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Figure 2–2:  Separations achieved on an Amide-80 column with fluorescence detection of 
2-AB-labeled glycans released from MAbs. The retention time increases with the 
increasing molecular weight of glycans. The main glycan species in all the MAbs are G0, 
G1 and G2. Glycosylation pattern of MAb3 is different to those for MAb1 and MAb2, 
containing numerous peaks in the elution range of negatively charged complex glycans. 
Gradient elution: mobile phase A-acetonitrile; mobile phase B-250 mM ammonium 
formate, pH 4.4. 
  
MAb1 
MAb2 
MAb3 
Chapter Two         Hydrophilic interaction liquid chromatography of glycans 
- 38 - 
 
Table 2-2: Relative quantification of glycoforms from the monoclonal antibodies obtained 
by Amide-80 column coupled with fluorescence detection.  
Glycan Structure 
      % Area 
MAb1 MAb2 MAb3 
Unknown    <0.2 
G0-Fuc-GlcNAc 
 
<0.2 <0.2 0.5 
G0-GlcNAc 
 
2.4 3.7 3.1 
G0 
 
84.8 74.0 45.6 
Man5 
 
0.5 0.8 1.4 
Unknown   <0.2  
G1-GlcNAc 
 
<0.2 0.4 2.7 
G1 
 
6.8 12.1 21.5 
4.5 6.6 11.9 
Unknown    0.3 
Unknown    0.9 
Unknown    2.4 
G2 
 
0.7 1.5 5.0 
Unknown    0.9 
Unknown    0.6 
Unknown   <0.2  
Unknown    1.3 
G1+NANA 
 
<0.2   
Unknown    0.5 
Unknown   <0.2  
Unknown  <0.2 <0.2 0.9 
Unknown    <0.2 
Unknown    <0.2 
 GlcNAc;  fucose;  mannose;  galactose;  NeuAc  
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The peaks have been identified based on the retention times, since the procedure 
is standardised. Some minor species, such as Man5, G0-GlcNAc, G1-GlcNAc can 
also be identified, but they all represent less than 1% of the total peak area. It was 
not possible to identify peaks with less than 0.2% of the total peak area (Table 
2-2) and under these experimental conditions G1 structural isomers were only 
partially separated. MAb3 was shown to be significantly different to MAb1 and 
MAb2, containing a wide range of minor glycans that could not be identified by 
the standard procedure. The difference between these MAbs is expected, since 
MAb1 and MAb2 were expressed in Chinese hamster ovary (CHO) cell lines and 
MAb3 was expressed in murine NS0 cell line. The major differences in 
galactosylation and sialylation have been reported for the two cell lines [15, 18] 
which can also contribute to the immunogenicity of the drugs in humans [19, 20]. 
It is reasonable to expect that antibodies expressed in similar systems would 
present similar glycan profiles to these MAbs. 
Despite the high sensitivity of the fluorescence detection and the commercial 
availability of labelling kits, there are several limitations to this procedure.  
Fluorescent labelling is expensive and time-consuming, especially when large 
numbers of samples are analysed. Furthermore, fluorescence detection does not 
provide direct information about the structure of glycans and a single 
chromatographic run the using standard procedure requires nearly 3h. 
Therefore, a new approach was investigated for the separation of 2-AB labelled, 
native and reduced glycans from MAbs using a HILIC column with zwitterionic 
functionality (ZIC-HILIC), coupled with fluorescence and ESI-MS detection. 
2.3.2. ZIC-HILIC 
2.3.2.1. Separation of 2-AB labelled glycans 
A HILIC column with zwitterionic functionality (ZIC-HILIC) which was 
previously shown to separate glycopeptides and 2-aminopyridine labelled 
glycans [38, 78, 80] was tested for separation of 2-AB labelled glycans from 
RNase B and monoclonal antibodies. ZIC-HILIC was coupled to fluorescence 
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detection to achieve optimum sensitivity and for relative quantification of 
glycans. The ZIC-HILIC was further coupled with ESI-MS for identification of 
glycans previously observed using fluorescence detection. 
 
 
 
Figure 2–3: Fluorescence chromatogram of 2-AB labelled RNase B glycans. Additional 
peaks that correspond to 2-AB labelled high mannose glycans cleaved by Endo H are 
observed in fluorescence chromatogram and they were eluted before the PNGase F 
released glycans with the same number of mannose residues.  
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Figure 2–4: Separation of 2-AB labelled glycans from RNase B using ZIC-HILIC coupled 
with ESI-MS. Base peak chromatogram (BPC) in mass range from 1100 to 3000 and 
extracted ion chromatograms (EIC) of singly protonated Man5-GlcNAc, Man5, Man6-
GlcNAc and Man6. Width for selected chromatogram traces was ± 0.03 Da. 
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Figure 2–3 shows a fluorescence chromatogram of RNase B obtained using ZIC-
HILIC column and considering the most likely HILIC separation mechanism, the 
expected retention time would increase with increasing molecular weight of 
glycans. Compared to the amide HILIC column, several additional smaller peaks 
were observed in the ZIC-HILIC chromatogram, that were eluted before the 
main peaks of Man5-Man9 glycans. It is assumed that some of the glycans that 
are clearly resolved in the ZIC-HILIC chromatogram, co-eluted when HILIC 
amide was used as a stationary phase. The structures of 2-AB labelled glycans 
were further characterised using ZIC-HILIC coupled with ESI-MS (Figure 2–4). 
This confirmed the proposed order of elution, where larger glycans were more 
strongly retained by the ZIC-HILIC stationary phase. The retention times with 
relative peak areas and proposed structures as discussed below are summarised 
in Table 2-3. With ESI-MS only Man5 and Man6 were identified, observed as the 
singly protonated ions. However, sensitivity in ESI-MS was lower compared to 
the fluorescence detection, which resulted in the loss of signals for Man7, Man8 
and Man9 glycans. Due to the correlation between relative quantitative data 
obtained by amide HILIC and ZIC-HILIC coupled with fluorescence, the 
proposed peak assignment is as shown in Table 2-3.  
Additional peaks, previously not observed by HILIC-amide/fluorescence, were 
found in the fluorescence chromatogram of RNase B and were eluted before the 
high mannose glycans. Using ESI-MS, they were identified as truncated high 
mannose glycans, lacking a core GlcNAc. Truncated glycans are common 
degradation products of enzyme Endoglycosidase H (Endo H), which has 
specificity for high mannose glycans and hydrolyses the bond between the core 
GlcNAcs. It is suggested that contamination with Endo H was present in the 
PNGase F. When HILIC with an amide type column was used, the truncated 
glycans were most likely co-eluted with the main glycan products of cleavage by 
PNGase F, which explains the bad peak shapes in the fluorescence 
chromatogram (Figure 2–1). The ZIC-HILIC column exhibited enhanced 
resolving power for 2-AB labelled high mannose glycans compared to the HILIC 
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amide-80, resulting in the complete separation of various products of PNGase F 
and Endo H degradation in the shorter chromatographic run. 
The ZIC-HILIC column was also used for separation of 2-AB labelled glycans 
from monoclonal antibodies. A binary gradient consisting of acetonitrile and an 
aqueous solution of acetic acid was used for elution in order to make the method 
compatible for on-line coupling with ESI-MS. Fluorescence chromatograms of 
MAb1, MAb2 and MAb3 are shown in Figure 2–5 to Figure 2–7, with relative 
quantification data summarised in Table 2-4. The peaks were assigned based on 
the ESI-MS results described below. 
Some differences were observed when ZIC-HILIC was compared to the results 
obtained by the amide HILIC method. The selectivity of ZIC-HILIC for 2-AB 
labelled glycans was different to amide HILIC, with Man5 being eluted before 
G0. G0-Fuc glycan species was identified in MAb1 and MAb2 samples, which 
was not previously seen by using the amide HILIC column. G0-Fuc and Man5 
glycans were not fully resolved. The loss of separation could be due to the large 
dead volume after the column, mainly contributed by the tubing and the flow-
cell (16 µL) of the fluorescence detector. The peaks could appear as only partially 
separated if the data acquisition rate was not sufficient (0.25 points/s). Due to the 
peak overlapping, the relative peak areas of minor glycans are approximate and 
correlation between amide HILIC and ZIC-HILIC for the major glycan species is 
satisfactory. Differences in relative quantification could be mainly contributed by 
co-elution of glycans. Several minor glycans were observed in MAbs samples 
when LC was coupled with fluorescence, but these could not be identified by 
ESI-MS due to lower sensitivity. A lower number of peaks was observed using 
ZIC-HILIC compared to the HILIC amide standard method. This could be 
explained by incomplete separation of 2-AB glycans using ZIC-HILIC and 
therefore minor species were hidden in the broad peaks of major glycan species. 
However, it has to be emphasized that a lower sample amount was injected onto 
the ZIC-HILIC column than the amide HILIC column, which could contribute to 
the lower number of observed peaks.  
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Table 2-3: Relative quantification of glycoforms from the RNase B obtained by ZIC-HILIC column coupled with fluorescence detection. Theoretical m/z of 
most likely ions to be found by ESI-MS are listed in the table. The Man5, Man5-GlcNAc, Man6 and Man6-GlcNAc were confirmed by ESI-MS. 
 Glycan Structure 
(m/z)theoretical, 2-AB 
[M+H]+ 
[M+2H]2+ 
Ions 
found 
Retention time / 
min 
Relative peak 
area  / % 
(Man)2 
(Man)3(GlcNAc)1 
Man5-GlcNAc 
 
1152.43 
576.72 
[M+H]+ 
 
27.9 10.8 
(Man)2 
(Man)3(GlcNAc)2 
Man5 
 
1355.51 
678.26 
[M+H]+ 
 
30.0 35.0 
(Man)3 
(Man)3(GlcNAc)1 
Man6-GlcNAc 
 
1314.48 
657.74 
[M+H]+ 
 
36.7 4.6 
(Man)3 
(Man)3(GlcNAc)2 
Man6 
 
1517.56 
759.28 
[M+H]+ 
 
38.9 22.6 
(Man)4 
(Man)3(GlcNAc)2 
Man7 
 
1679.61 
840.31 
 
45.3 
46.5 
9.5 
(Man)5 
(Man)3(GlcNAc)2 
Man8 
 
1841.67 
921.34 
 53.5 10.7 
(Man)6 
(Man)3(GlcNAc)1 
Man9-GlcNAc 
 
1800.64 
900.82 
 57.3 2.1 
(Man)6 
(Man)3(GlcNAc)2 
Man9 
 
2003.72 
1002.36 
 58.5 4.6 
Chapter Two         Hydrophilic interaction liquid chromatography of glycans 
- 45 - 
 
 
 
 
 
 
 
 
Figure 2–5: Fluorescence chromatogram of 2-AB labelled glycans from MAb1. Gradient 
elution: mobile phase A-acetonitrile; mobile phase B-17 mM acetic acid, pH 3.25. The 
chromatogram confirmed the high degree of fucosylation and low level of 
galactosylation in MAb1 as expected for the MAb expressed in CHO cell line. 
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Figure 2–6: Fluorescence chromatogram of 2-AB labelled glycans from MAb2. Gradient 
elution: mobile phase A-acetonitrile; mobile phase B-17 mM acetic acid, pH 3.25. 
Similarly as for MAb1, a high content of fucosylated species with low degree of 
galactosylation was observed in the MAb2 glycan profile. 
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Figure 2–7: Fluorescence chromatogram of 2-AB labelled glycans from MAb3. Gradient 
elution: mobile phase A-acetonitrile; mobile phase B-17 mM acetic acid, pH 3.25. Mab3 
exhibited higher degree of galactosylation compared to MAb1 and MAb2. Multiple 
unassigned peaks were observed, indicating more complex glycan profile, as previously 
confirmed by amide HILIC. 
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Table 2-4: Relative quantification of glycoforms from the monoclonal antibodies obtained 
by ZIC-HILIC coupled with fluorescence detection.  
Glycan Structure 
% Area 
MAb1 MAb2 MAb3 
G0-GlcNAc-Fuc 
 
  0.4 
G0-GlcNAc 
 
4.1 <0.2 2.9 
Unknown    0.62 
G0-Fuc 
 
1.6 0.9  
Man5 
 
1.3 <0.2 1.9 
G0 
 
80.2 79.4 49.8 
Unknown    0.4 
Unknown  1.5   
G1 
 
3.4 7.3 13.7 
7.0 10.9 21 
Unknown    <0.2 
G2 
 
0.7 1.0 8.0 
Unknown  0.2 <0.2  
Unknown    0.7 
Unknown    0.4 
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Reproducibility of retention times and peak intensities was good when the same 
sample was injected consecutively. A relative standard deviation of retention 
times of approximately 0.5-1.1% was observed between different samples (not 
shown), with the difference increasing with the increasing retention time. It is 
assumed that some of the components in the original formulations of monoclonal 
antibodies were not fully removed during the sample preparation and they 
interfered with the column chemistry. The issue regarding sample additives will 
be further discussed later in the section on separation of 2-AB labelled glycans 
using ZIC-HILIC coupled with ESI-MS. 
The ZIC-HILIC separation was further coupled to ESI-MS for structural 
assignment of peaks obtained by ZIC-HILIC/Fluorescence. The MS 
chromatograms are shown in Figure 2–8 to Figure 2–10. The main ion species for 
all the identified glycans were singly protonated and sodiated ions (not shown). 
Slightly lower sensitivity compared to the fluorescence detection was achieved; 
however, all main glycans that were previously observed by the amide HILIC 
have been identified and they are summarised in Table 2-5. Furthermore, besides 
G0-Fuc, two other previously unobserved glycan species were identified (Table 
2-5), with the compositions (Hex)2(HexNAc)1(Man)3(GlcNAc)2 and 
(Hex)2(HexNAc)1(dHex)1(Man)3(GlcNAc)2. Three possible structures could be 
assigned to both observed m/z values; one complex structure with α-
galactosylation on the 3-arm, and two hybrid type structures with one or two 
mannose units on the 6-arm. For the m/z 1704.65 two peaks were found, however 
it was not possible to elucidate the structure for the two peaks and three possible 
structures were proposed for the observed m/z. For the early eluted peak only 
singly charged [M+H]+ ion was observed, whereas for the late eluted peak singly 
and doubly protonated species were found. All proposed structures would be 
possible to find in MAbs expressed in murine NS0 cell line [18]; however, the 
obtained data do not provide enough information to conclude which structure is 
correct.  
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In MAb1 and MAb2 samples, two peaks have been observed for G0-GlcNAc-Fuc 
chromatogram trace (m/z=1234.48), which could be due to the separation of 
structural isomers. Using the GlycoSuite database of glycan structures, two likely 
structures were found, with GlcNAc attached to 3- or 6-arm of the glycan core; 
however, the confirmation and structural elucidation with the existing data are 
not possible. Interestingly, for MAb3 only one G0-GlcNAc-Fuc peak was 
observed, which might suggest that the difference in glycosylation pattern was 
due to the different expression systems of these MAbs. 
The main advantage of the new ZIC-HILIC method compared to the standard 
HILIC procedure is shorter analysis time, which was reduced from 160 min to 85 
min, including the equilibration time. Furthermore, the method was optimised 
for on-line coupling with ESI-MS, since a low concentration of acetic acid was 
used as an eluent. On the other hand, the standard procedure required a high 
concentration of ammonium formate buffer and was not suitable for the on-line 
ESI-MS detection of 2-AB labelled glycans due to the ionisation suppression. A 
common approach for identification of glycans using the HILIC amide column 
includes the use of 2-AB glycan standards and identification based on the 
retention time may require further collection of glycan fractions for confirmation 
of structures by MS. It is important to emphasise that not all the glycans that can 
be found in monoclonal antibodies are commercially available and prices for 
purified and labelled glycans are often very high. The analysis of minor species is 
therefore extremely challenging and complete structural assignment of peaks in 
fluorescence chromatograms is not always possible.  
Despite the lower sensitivity there are some clear advantages of using ESI-MS 
instead of fluorescence detection. The MS detection enables extraction of a single 
chromatogram trace which is very useful when complex samples with co-eluting 
compounds are being analysed. As shown in Figure 2–10, the glycan G1-GlcNAc 
co-eluted with G0 glycan under the applied experimental conditions and it 
cannot be seen by using fluorescence detection alone. Since the dead volume 
after the column is reduced when using ESI-MS detection, the G0-Fuc and Man5 
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that were only partially resolved when using fluorescence detection, were now 
almost completely separated. 
 
 
Figure 2–8: Separation of 2-AB labelled glycans from MAb1 using ZIC-HILIC coupled 
with ESI-MS. Base peak chromatogram in mass range 1200-3000, extracted ion 
chromatograms of singly and doubly protonated ions of major 2-AB glycans and native 
G0 glycan, indicating incomplete labelling.  
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Figure 2–9: Separation of 2-AB labelled glycans from MAb2 using ZIC-HILIC coupled 
with ESI-MS. Base peak chromatogram in mass range 1100-3000 and extracted ion 
chromatograms of singly and doubly protonated ions of major 2-AB glycans and native 
G0 glycan. Double peak of G0-GlcNAc indicates in-source fragmentation. Two peaks are 
observed for G0-GlcNAc-Fuc.  
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Figure 2–10: Separation of 2-AB labelled glycans from MAb3 using ZIC-HILIC coupled 
with ESI-MS. Base peak chromatogram in mass range 1100-3000, extracted ion 
chromatograms of singly and doubly protonated ions of major 2-AB glycans and native 
G0 glycan. Double peaks of G0-GlcNAc and G1-GlcNAc indicate in-source 
fragmentation.  
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Various aqueous mobile phases were tested for the elution of 2-AB labelled 
glycans, including acetic acid, ammonium formate and ammonium acetate, using 
the same gradient profile as previously described. The composition of the mobile 
phase did not significantly affect the retention of the 2-AB glycans; however, it 
had a large impact on elution of contaminants originating from the samples. The 
MAbs and other biological formulations usually contain detergents, such as 
polysorbates (Tween), that might not be completely removed during the sample 
clean-up. If they are present in sufficiently high concentrations, the surface 
chemistry can be changed which could explain sample-to-sample variations in 
retention times. Since the detergents are polymeric mixtures, they did not elute 
as a single peak but over a large time window, which interfered the least with 
the elution of glycans when acetic acid was used as the mobile phase (not 
shown). When ammonium formate and ammonium acetate were used as a 
mobile phase, the contaminants started to elute earlier and due to their good 
ionisation in ESI-MS source, the ionisation of co-eluting glycans was supressed 
and the signal was therefore reduced. Late-eluted minor glycans found in MAb3 
could not be detected by ESI-MS, most likely due to the presence of contaminants 
in the sample. The sample preparation was further optimised in later chapters, 
where additional cleaning steps were introduced. Fluorescence detection offers 
an advantage compared to the ESI-MS detection, since contaminants present 
from the original formulation do not interfere with the signal for fluorescently-
labelled glycans. However, it is important to emphasise that labelling is not 
always quantitative and in all the MAb samples, native G0 glycan was found, 
which exhibited higher retention compared to the 2-AB labelled form.  
Similarly as observed for amide HILIC, the MAb3 glycan profile obtained by 
ZIC-HILIC was different to glycan profiles of MAb1 and Mab2, which is in 
agreement with the proposal that these MAbs originate from different expression 
systems. However, minor glycans in these MAbs could not be identified with 
amide HILIC or ZIC-HILIC separation of 2-AB labelled glycans. 
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Table 2-5: Theoretical m/z and retention times of 2-AB labelled glycans released from monoclonal antibodies.  
Glycan 
composition 
Structure Abbr. 
(m/z)theoretical, 2-AB  
[M+H]+ 
[M+2H]2+ 
Ions 
found 
Retention  
time / min MAb1 MAb2 MAb3 
(HexNAc)1 
(Man)3(GlcNAc)2  
G0-GlcNAc-Fuc 
1234.48 
617.75 
[M+H]+ 
 
19.9 
24.9 
+ 
+ 
+ 
+ 
+ 
- 
(HexNAc)1 
(dHex)1 
(Man)3(GlcNAc)2  
G0-GlcNAc 
1380.54 
690.77 
[M+H]+ 
 
23.8 - - + 
(HexNAc)2 
(Man)3(GlcNAc)2  
G0-Fuc 
1437.56 
719.28 
[M+H]+ 
 
28.7 + + - 
(Hex)2 
(Man)3(GlcNAc)2 
 
Man5 
1355.51 
678.26 
[M+H]+ 
 
30.0 + + + 
(HexNAc)2 
(dHex)1 
(Man)3(GlcNAc)2  
G0 
1583.62 
792.31 
[M+H]+ 
 
32.2 + + + 
(Hex)1(HexNAc)1 
(dHex)1 
(Man)3(GlcNAc)2  
G1-GlcNAc 
1542.59 
771.80 
[M+H]+ 
 
33.2 - - + 
                        Table 2-5 continued< 
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(Hex)2(HexNAc)1 
(Man)3(GlcNAc)2 
 
 
 
Hyb1 
1558.59 
779.80 
 
[M+H]+ 
 
37.7 - - + 
(Hex)1(HexNAc)2 
(dHex)1 
(Man)3(GlcNAc)2  
G1 
1745.67 
873.34 
[M+H]+ 
[M+2H]2+ 
39.1 
40.5 
+ 
+ 
+ 
+ 
+ 
+ 
(Hex)2(HexNAc)1 
(dHex)1 
(Man)3(GlcNAc)2 
 
 
 
Hyb1F / 
G2-GlcNAc 
1704.65 
852.83 
[M+H]+ 
[M+2H]2+ 
41.3 - - + 
(Hex)2(HexNAc)2 
(dHex)1 
(Man)3(GlcNAc)2  
G2 
1907.73 
954.37 
[M+2H]2+ 46.8 + + + 
  + confirmed; - not found in the sample.
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2.3.2.2. Separation of native glycans 
Initially, the ZIC-HILIC column was tested for the separation of 2-AB labelled 
glycans. Several aqueous mobile phases with different pH and ionic strength, 
using ammonium formate, ammonium acetate or acetic acid as the buffer were 
tested. A number of different gradient profiles were evaluated, with the best 
profile obtained using 17 mM acetic acid. The experimental conditions showing 
the best separation of 2-AB labelled glycans were used for further method 
development for the separation of native and reduced glycans. In this initial 
work, better sensitivity in ESI-MS experiments was achieved by using a low 
concentration of acetic acid as the aqueous mobile phase. This composition 
reduced the background noise and improved the ionisation efficiency, which 
was significantly reduced when ammonium was present in the buffer solution. 
 
  
Figure 2–11: Separation of linear oligosaccharides at a concentration of 3 µg/ml: (a) 
maltopentaose; (b) maltohexaose; (c) maltoheptaose. Gradient elution: mobile phase A-
acetonitrile; mobile phase B-34 mM acetic acid, pH 3.0. 
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Linear oligosaccharides containing 5-7 glucose units and high mannose, 
mannose 3 (Man3) and mannose (Man9), glycan standards were used for testing 
the capability of the ZIC-HILIC column for the separation of reducing glycans. 
For all types of reducing glycan standards, linear oligosaccharides and high 
mannose, the same behaviour was observed. Glycan anomers were separated 
and signals for glycans appeared as double peaks due to mutarotation (Figure 2–
11 and Figure 2–12).  
Separation of Man3 and Man9 glycan standards on the ZIC-HILIC column was 
further tested under different chromatographic conditions, using various acids 
and buffers as the eluent B, with the same gradient profile as previously 
described.  When 0.1% formic acid, 0.1% acetic acid, 0.1% propionic acids were 
used, a strong double peak was observed in the base peak chromatogram (BPC) 
that corresponded to Man3 glycan, with no significant difference in sensitivity or 
retention time. For Man9 glycan, which was eluted at higher water content, 
sensitivity was much lower compared to Man3 (Figure 2–12). On the other hand, 
sensitivity for Man3 and Man9 was greatly reduced when ammonium buffers 
were used as aqueous mobile phase due to the reduced ionisation efficiency. 
Sensitivity decreased with the increasing ammonium concentration in the mobile 
phase and when 60 mM ammonium formate buffer was used as an eluent, the 
peak for the Man9 glycan could no longer be seen in the BPC, whereas the 
intensity of the peak for Man3 remained the same as in 10 mM ammonium 
formate and shifted to the lower retention time (Figure 2–13). 
The mobile phase composition had also a great effect on the formation of ions in 
the ESI source. Other parameters that affected the formation of ions were the 
presence of contaminants in the sample, and the size and structure of glycans. In 
positive ion ESI-MS mode glycans tend to form protonated species and sodium 
adducts; a higher proportion of ammonium glycan adducts is expected when 
ammonium is present in the sample or in the mobile phase.  
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Figure 2–12: Man3 (concentration of 10 µg/mL) and Man9 (concentration of 20 µg/mL) 
standards. Gradient elution: mobile phase A-acetonitrile, mobile phase B-0.1% formic 
acid (a), 0.1% acetic acid (b), 0.1% propionic acid (c). No significant difference in retention 
times or signal intensity is observed in BPC (m/z=800-3000). 
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Figure 2–13: Man3 (concentration of 10 µg/mL) and Man9 (concentration of 20 µg/mL) 
standards. Gradient elution: mobile phase A-acetonitrile, mobile phase B-10 mM (a) and 
60 mM (b) ammonium formate pH 4.0. Intensity of the signal for Man3 glycan in BPC 
(m/z=800-3000) remained the same when higher buffer concentration was used and it 
shifted to a lower retention time. Signal for Man9 glycan can no longer be observed when 
higher buffer concentration was used.  
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Figure 2–14: Mass spectra of Man9 glycan: singly charged ions (A) and doubly charged 
ions (B). Gradient elution: mobile phase A-acetonitrile, mobile phase B-0.1% acetic acid. 
The main adducts are singly and doubly protonated and sodiated ions. Ammonium 
adducts are present, most likely due to the ammonium contamination in the sample. 
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Figure 2–15: Mass spectra of Man9 glycan: singly charged ions (A) and doubly charged 
ions (B). Gradient elution: mobile phase A-acetonitrile, mobile phase B-10 mM 
ammonium formate. The dominating ions are singly and doubly charged ammonium 
adducts.  
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Table 2-6: Man3 and Man9 adducts found in mass spectra under different experimental 
conditions. 
Possible ions 
Theoretical m/z 
  
[M+H]+ 911.35 *,‡ 1883.68 
[M+Na]+ 933.33 1905.66 
[M+NH4]
+  1900.71 
[M+2H]2+  942.34 
[M+2Na]2+  964.33 * 
[M+2NH4]
2+  959.37 
[M+H+Na]2+  953.33 
[M+H+NH4]
2+  950.86 ‡ 
[M+Na+NH4]
2+  961.85 
* the most abundant ion in acetic acid 
‡ the most abundant ion in 10 mM ammonium formate 
 
 
For Man3 the most abundant ion under all experimental conditions used was the 
pseudomolecular ion [M+H]+ and it did not form any doubly charged species. 
With increasing molecular mass, formation of doubly charged ions becomes 
more prominent. For Man9 glycan besides the main protonated and sodiated 
ions, singly and doubly charged ammonium adducts were observed when 0.1% 
acetic acid was used as the eluent B, which indicated the presence of ammonium 
in the sample (Figure 2–14). When ammonium was present in the mobile phase, 
the ammonium adducts became the dominant ions for Man9 glycan (Figure 2–
15). The observed ions for Man3 and Man9 glycans are summarised in Table 2-6. 
When the typical ionisation pattern under certain experimental conditions is 
understood, it can be a valuable tool in identifying unknown glycans in a 
sample. Glycans also exhibit a specific isotope pattern which can be calculated by 
appropriate software. The relative intensity of peaks in the isotope pattern can be 
used for an additional confirmation of glycan MS signal.   
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Figure 2–16: Separation of native glycans from RNase B using ZIC-HILIC column 
coupled with ESI-MS. Gradient elution: mobile phase A-acetonitrile; mobile phase B-34 
mM acetic acid, pH 3.0. Only the most abundant glycans, Man5, Man6 and Man8, are 
found in the BPC. Due to the mutarotation, glycans eluted as double peaks. Man7 and 
Man9 are not observed due to the peak broadening. 
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The method was applied to the RNase B glycans and under the conditions used, 
only peaks for the most abundant glycans, Man5, Man6 and Man8, could be 
identified. Reducing oligosaccharides appeared as double peaks due to 
mutarotation and were only partially resolved (Figure 2–16). In addition, it was 
observed that peak broadening due to the mutarotation process reduced the 
sensitivity, therefore minor species such as Man7 and Man9 could not be found 
in the BPC, although the MS signals were observed in the accumulated mass 
spectrum (Figure 2–17). 
 
 
Figure 2–17: Accumulated mass spectrum of the whole native glycan elution range. All 
glycans expected to be present in RNase B, Man5-Man9, are found in the mass spectrum. 
Relative intensities are in agreement with the data obtained by fluorescence detection.  
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Similar behaviour has already been reported for the separation of glycans on 
graphitized carbon columns [82, 122]. The double peaks appearing due to 
mutarotation could be avoided either by reducing the glycans to alditols using 
sodium borohydride, or by increasing the pH which accelerates the mutarotation 
process.  
2.3.2.3. Separation of reduced glycans 
Due to the pH limitations of the silica-based ZIC-HILIC column, the anomers of 
RNase B oligosaccharides were removed by reduction prior to the separation 
(Figure 2–18). Following the reduction, single peaks corresponding to Man5 to 
Man9 were found in the BPC. For the most abundant glycans, Man5 and Man6, 
double peaks that correspond to the native forms could be observed due to 
incomplete reduction but they did not interfere with the separation of the 
reduced glycans. In addition, peaks for Man7 structural isomers were partially 
resolved (Figure 2–18). The RNase B glycan profile corresponded well to the 
glycan profile obtained by the standard method for separation of 2-AB labelled 
glycans on an amide and a ZIC-HILIC column, coupled with fluorescence 
detection. The order of elution was also the same for the reduced glycans as was 
observed for the separation of 2-AB glycans on either amide HILIC or ZIC-HILIC 
stationary phases, which confirmed the HILIC separation mechanism. The 
accumulated mass spectrum over the glycan elution range, Figure 2–19, shows 
that under the given conditions, oligosaccharides gave the strongest signal for 
the pseudomolecular ions [M+H]+ and [M+Na]+. Most significantly, using this 
new approach the sample preparation was simplified and the analysis time was 
reduced from 145 min to 105 min without the equilibration time, compared to the 
standard procedure. 
Similar behaviour was observed for the glycans released from MAbs as for 
RNase B oligosaccharides, with native glycans appearing as double peaks due to 
mutarotation (data not shown).  The ZIC-HILIC chromatograms for reduced 
oligosaccharides obtained from MAbs are shown in Figure 2–20 and Figure 2–21 
and the data are summarised in Table 2-7. The MAb glycan profiles also 
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correlated well with the profiles obtained using the standard procedure for 2-AB 
labelled glycans. In all of the samples a small double peak correlating to a small 
amount of unreduced G0 was observed, but it did not interfere with the 
separation of the reduced glycans.  
 
 
 
Figure 2–18: Separation of reduced glycans from RNase B using ZIC-HILIC column 
coupled with ESI-MS. Gradient elution: mobile phase A-acetonitrile; mobile phase B-34 
mM acetic acid, pH 3.0. Man5-Man9 glycans are found in the BPC. Man7 glycans are 
partially separated. Small amounts of unreduced glycans which do not interfere with the 
separation of reduced glycans are present in the sample. 
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Figure 2–19: Accumulated mass spectrum of the whole reduced RNase B glycan elution 
range. Man5-Man9 glycans are found in the mass spectrum, with relative amounts: 
Man5>Man6>Man8>Man7>Man9. 
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Figure 2–20: Base peak chromatograms (m/z=1100-3000) of reduced glycans released 
from MAbs obtained with ZIC–HILIC coupled with ESI–MS. Gradient elution: mobile 
phase A-acetonitrile; mobile phase B-34 mM acetic acid, pH 3.0. Major glycans: G0-
GlcNAc-Fuc, G0-GlcNAc, G0, G1 and G2 are found in the BPC. G1 isomers are partially 
separated.  
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Figure 2–21: BPC and extracted ion chromatograms (EICs) of glycans from MAb3. 
Gradient elution: mobile phase A-acetonitrile; mobile phase B-34 mM acetic acid, pH 3.0. 
G0, Man5 and G1-GlcNAc are partially overlapped. 
20 25 30 35 40 45 50 
Time / min 
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
In
te
n
s
it
y
 x
 1
0
5
 
BPC (m/z=1100-3000) 
EIC (m/z=1116.43) 
EIC (m/z=1262.49) 
EIC (m/z=1465.57) 
EIC (m/z=1424.54) 
EIC (m/z=1237.46) 
EIC (m/z=1627.62) 
EIC (m/z=1789.67) 
   
- 71 - 
 
Table 2-7: Reduced glycans, found in MAbs by ZIC-HILIC method.  
 
Glycan 
composition 
Structure Abbr. 
(m/z)theoretical, red  
[M+H]+ 
[M+2H]2+ 
Ions 
found 
Retention 
time / min 
MAb1 MAb2 MAb3 
(HexNAc)1 
(Man)3(GlcNAc)2  
G0-GlcNAc-Fuc 
1116.43 
558.72 
[M+H]+ 
23.9 
26.3 
+ 
+ 
+ 
+ 
+ 
- 
(HexNAc)1 
(dHex)1 
(Man)3(GlcNAc)2  
G0-GlcNAc 
1262.49 
631.75 
[M+H]+ 24.6 + + + 
(HexNAc)2 
(dHex)1 
(Man)3(GlcNAc)2  
G0 
1465.57 
733.29 
[M+H]+ 29.3 + + + 
(Hex)1(HexNAc)1 
(dHex)1 
(Man)3(GlcNAc)2  
G1-GlcNAc 
1424.54 
712.77 
[M+H]+ 30.0 - + + 
(Hex)2 
(Man)3(GlcNAc)2 
 
Man5 
1237.46 
619.23 
[M+H]+ 30.3 + + + 
(Hex)1(HexNAc)2 
(dHex)1 
(Man)3(GlcNAc)2  
G1 
1627.62 
814.31 
[M+H]+ 
[M+2H]2+ 
34.7 
35.8 
+ 
+ 
+ 
+ 
+ 
+ 
(Hex)2(HexNAc)2 
(dHex)1 
(Man)3(GlcNAc)2  
G2 
1789.67 
895.34 
[M+H]+ 
[M+2H]2+ 
42.0 - + + 
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Figure 2–22: Accumulated mass spectrum of the whole reduced MAb3 glycan range. All 
the major glycan species are identified with the main singly charged protonated ion. 
Singly charged sodium adducts are observed for the most abundant glycans.  
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Similar to the results for the RNase B glycans, the accumulated mass spectrum 
(Figure 2–22) over the glycan elution range shows that the most abundant 
species were the protonated species and sodium adducts. The G1 structural 
isomers were partially resolved, indicating that the ZIC-HILIC column has the 
capability to separate structural isomers, as also previously reported for AP-
labelled glycans and glycopeptides [38, 80]. Similarly as seen for the separation 
of 2-AB labelled glycans, two peaks for G0-GlcNAc-Fuc were observed in MAb1 
and MAb2, and one peak was observed in MAb3 glycan samples. Although the 
retention mechanism governing the ZIC-HILIC separation of glycans is not 
completely understood, it has been suggested that the structural recognition 
capability is based on hydrophilic partitioning of glycans and electrostatic 
interaction between glycans and zwitterionic sulfobetaine groups on the surface 
[80]. For G0-GlcNAc several peaks were also observed which indicated the 
presence of in-source fragmentation of G0 and G1 glycans. Fragmentation will be 
discussed in detail in Chapter 3. 
Due to the poor ionisation of native and reduced glycans in the ESI source, the 
main disadvantage of using ESI-MS instead of fluorescence is the loss of 
sensitivity. However, despite lower sensitivity, all of the most abundant glycans 
in the MAbs were identified under the described experimental conditions and 
the glycan profiles correlated well with the profiles obtained with the standard 
procedure. At the same time, fluorescence labelling has the disadvantage of 
being both relatively expensive and sometimes non-quantitative. Therefore, this 
new approach offers a good alternative for fast and reliable glycan profiling of 
MAbs. None of the described methods provided complete information about 
MAb glycosylation, which indicated the need for further method development 
and testing new stationary phases in order to save time required for 
derivatization procedures or chromatographic separation. There are a few 
parameters to be considered; sample preparation time and costs, sensitivity in 
fluorescence and ESI-MS detection, structural information and time of a 
chromatographic run. 
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In quality control, a consistent glycan profile over time obtained by fluorescence 
detection may provide sufficient information about the protein glycosylation. On 
the other hand, clone selection in production of biotherapeutics, looking for 
correlations between glycosylation and illnesses, or understanding biological 
activity of the naturally occurring and recombinant glycoproteins may require 
detailed information about glycosylation patterns which cannot be obtained by a 
single method. 
2.4. Conclusions 
In this chapter, a simpler and faster HILIC separation of 2-AB labelled, native 
and reduced glycans from RNase B and monoclonal antibodies using a ZIC-
HILIC column has been described. It is demonstrated that the ZIC-HILIC column 
has a good capability for structural recognition for isomeric, neutral, reduced 
and 2-AB labelled glycans. The new ZIC-HILIC methods were compared to a 
separation of 2-AB labelled glycans on an Amide-80 column, coupled with 
fluorescence detection, yielding a good correlation between the glycan profiles. 
Using a ZIC-HILIC column, the time required for separation of 2-AB glycans was 
significantly reduced compared to the standard procedure. The separation of 2-
AB glycans was optimized for on-line coupling with fluorescence and ESI-MS 
detection to obtain quantitative information and for structural assignment of 
peaks. Different selectivity of ZIC-HILIC was observed compared to the Amide-
80 column and two glycan species that were not previously identified by the 
standard method were found in the MAbs samples. Furthermore, the use of the 
ZIC-HILIC method for separation of reduced glycans was demonstrated. The 
ZIC-HILIC method exhibited good retention time reproducibility and due to the 
good chromatographic resolution and ESI-MS sensitivity, additional fluorescence 
labelling was not required which significantly lowers the cost of the analysis. 
This work demonstrates that the ZIC-HILIC separation is suitable for routine 
profiling of monoclonal antibodies and offers a good alternative to the more 
conventional separations using HILIC amide-80 and graphitized carbon 
columns. 
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Chapter Three 
 3. Separation of glycans using graphitized carbon 
3.1. Introduction 
A very promising method for analysis of glycans from recombinant proteins is 
the use of a graphitized carbon column coupled with ESI-MS. It still has not 
gained the popularity of HILIC, since the separation mechanism is not yet well 
understood and no databases for structural assignment are available [86]. The 
most widely used porous graphitized carbon (PGC) columns in glycosylation 
analysis are Hypercarb™ columns (Thermo Fisher Scientific). Graphitized carbon 
has a stereo-selective surface with the capability to separate closely related 
compounds and it is stable over a wide pH range (pH 1-14). Retention of native 
and reduced glycans on graphitized carbon is driven by hydrophobic, polar and 
ionic interactions [86, 122, 123]. The strength of the interaction with the PGC 
stationary phase depends on the area in contact with the surface, and 
consequently also on the geometry and type of the functional groups in the 
molecule [124]. Due to the described properties, one of the main advantages of 
graphitized carbon is its isomer separation power, which is superior compared to 
HILIC. Binary gradients consisting of acetonitrile and an aqueous phase 
containing volatile buffers are commonly used for elution of glycans. Ionic 
strength and pH of the mobile phase have little impact on the elution of neutral 
glycans; however, the effect is much more pronounced for highly sialylated 
glycans which require use of buffers with some ionic strength to achieve elution 
[87]. Since the higher buffer concentrations negatively influence the ionisation 
efficiency for glycans, the choice of the mobile phase will strongly depend on the 
type and charge of analysed glycans.  
PGC has been shown to successfully separate high mannose, hybrid and 
complex type glycans from natural sources [37, 82-84, 125], and recombinant 
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glycoproteins [37, 85]. Most of the published work has been performed using 
reduced [37, 84, 85, 126-128] and 2-aminopyridine labelled glycans [129, 130], 
since analysis of native glycans usually results in undesirable separation of 
anomers [122]. Separation of anomers can be partially suppressed by using 
ammonia with high pH > 10 which enhances mutarotation [122, 131]; however, if 
the process is not fast enough, peak broadening may be observed [86, 122]. 
Graphitized carbon stationary phases can also be applied to permethylated 
glycans [132]. Permethylation increases ionisation efficiency of glycans and it is 
useful for fragmentation of glycans using tandem MS and can provide additional 
information about linkages and branching due to the extensive cross-ring 
fragmentations. On the other hand, the separation of permethylated glycan 
isomers using graphitized carbon might be more challenging compared to the 
separation of native and reduced glycan isomers. 
In a majority of cases, the separation of glycans by graphitized carbon has been 
coupled with MS detection. Glycans can be detected in positive or negative ion 
mode; however, the ionisation efficiency for negatively charged glycans is 
promoted in the negative ion mode [88] which can also lead to incorrect 
estimation of the relative amounts of charged and neutral glycans in the sample. 
The sensitivity in ESI-MS detection is largely enhanced using nano LC, due to the 
lower chromatographic dilution of the sample and more efficient ion transfer in 
the nano ESI-MS source [88, 131]. Improved absolute signal intensity in nano LC 
enables accumulation of high quality fragmentation data in the MS/MS mode 
and assignment of glycan structures [88]. Nano graphitized carbon LC in the 
form of a microfluidic chip was employed in profiling of complex N-glycan 
mixtures from human serum [89]. The nano LC separation method was coupled 
to orthogonal TOF-MS, which enabled identification of glycans based on high 
mass accuracy.  In a similar way, graphitized carbon chips were used for the 
analysis of mucin oligosaccharides and oligosaccharides from human milk and 
separation of a large number of components in a single run was demonstrated 
[133]. Recently, the use of an integrated microfluidics chip for glycan cleavage, 
clean-up, capture, separation using graphitized carbon stationary phase, and 
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nano ESI-TOF-MS has been reported. With the integrated chip, the complete 
analysis time was reduced from several hours to 10 min [134].  
In this chapter, the use of a standard-bore PGC column for separation of reduced 
glycans from monoclonal antibodies is demonstrated. Using graphitized carbon 
demonstrates several advantages compared to the amide HILIC and ZIC-HILIC 
approaches, with higher sensitivity obtainable. Additionally, PGC exhibits 
superior capability for separation of isobaric species with reduced time required 
for a chromatographic run compared to the HILIC methods. 
3.2. Materials and methods 
3.2.1. Reagents and chemicals 
Unless otherwise noted, all chemicals were of analytical grade. Acetonitrile was 
obtained from VWR International (Poole, UK). Acetic acid, ethanol, PNGase F, 
ribonuclease B (R7884), sodium borohydride, mannose 3 glycan, mannose 9 
glycan, maltopentaose, maltohexaose and maltoheptaose were obtained from 
Sigma (St. Louis, MO, USA). Formic acid, ammonium hydroxide and ammonium 
bicarbonate were obtained from Fluka (Steinheim, Germany). Propionic acid was 
purchased from Chem-Supply (Port Adelaide, Australia). 
3.2.2. Graphitized carbon coupled with ESI-MS 
The glycans released from the MAbs and the RNase B were reduced with sodium 
borohydride and desalted by ion-exchange chromatography, as described 
previously. Experiments were performed using a MicrOTOF-Q™ (Bruker 
Daltonik, Bremen, Germany) with an Agilent 1200 series binary pump and 
autosampler (Agilent, Santa Clara, CA, USA). Separations of native and reduced 
glycans were performed with Hypercarb™ column (2.1 x 150 mm, 5 µm; Thermo 
Fisher Scientific) installed in a column oven (Thermosphere, TS-130, 
Phenomenex, USA) at 30 ˚C.   
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Glycan standards and glycans released from RNase B were eluted using a binary 
step gradient; eluent A consisted of acetonitrile and eluent B consisted of 
aqueous solutions of various acids and volatile buffers, as noted. The flow-rate 
was set to 0.3 mL/min. Gradient: 7 to 40% A in 50 min, followed by a linear 
gradient 40 to 60% A in 10 min. The eluent composition was returned thereafter 
to 7% A in 1 min and the system re-equilibrated for 19 min prior to the next 
injection.  
Elution of glycans from MAbs was achieved using a binary gradient; eluent A 
consisted of acetonitrile and eluent B consisted of a aqueous solution of 17 mM 
(0.1% v/v) acetic acid in water, unless otherwise noted. The flow-rate was set to 
0.3 mL/min. Elution was achieved using a gradient from 7 to 30% A from 0-40 
min, followed by an isocratic wash step for 5 min at 60% A, and followed by an 
equilibration step for 15 min at 7% A. ESI-MS conditions were: capillary voltage, 
4.0 kV; drying temperature, 200 ˚C; drying gas flow, 8 L/min; nebulizer pressure, 
1.5 bar; scan range m/z 50-3000.  
3.3. Results and discussion 
3.3.1. Separation of linear oligosaccharides using PGC 
A graphitized carbon column was used for the separation of native and reduced 
glycans. For the method development, linear oligosaccharides, maltopentaose, 
maltohexaose, maltoheptaose, and high mannose glycan standards, Man3 and 
Man9, were used, all in the reducing form. Various experimental conditions were 
tested in order to achieve optimum separation with high ESI-MS sensitivity. It 
was expected that the presence of ammonium would reduce the ionisation 
efficiency, as previously demonstrated for ZIC-HILIC; however, ionisation of 
glycans in ESI-MS could be significantly different when graphitized carbon is 
used due to the mobile phase having a low content of acetonitrile. Since in HILIC 
the acetonitrile was the main source of chemical background, it was expected 
that sensitivity could be enhanced when graphitized carbon is used as a 
stationary phase.   
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Initially, the effect of mobile phase composition and pH on retention, ionisation 
of glycans and sensitivity was examined. Native linear oligosaccharides, 
maltopentaose, maltohexaose and maltoheptaose, were injected onto the 
graphitized carbon column and detected with ESI-MS in the positive ion mode.  
 
 
Figure 3–1: Separation of linear oligosaccharides at a concentration of 3 µg/ml. Gradient 
elution: mobile phase A-acetonitrile; mobile phase B-(a) 0.1% v/v formic acid, Vinj 5 µl; (b) 
0.1% v/v acetic acid, Vinj 5 µl; (c) 0.1% v/v propionic acid, Vinj 5 µl; (d) 10 mM ammonium 
formate pH 4.0, Vinj 10 µl; (e) 10 mM ammonium acetate pH 7.2, Vinj 10 µl; (f) 0.01% 
ammonia, Vinj 5 µl. 
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Due to the separation of anomers, the oligosaccharides were eluted as double 
peaks when acids or ammonium buffers were used. This behaviour has been 
previously reported for graphitized carbon and HILIC stationary phases. 
However, compared to the amide HILIC and ZIC-HILIC, the graphitized carbon 
can be used over a wider pH range which allows additional choices of mobile 
phases with high pH, such as ammonia. When 0.01% ammonia solution, pH 10.6, 
was used as the aqueous mobile phase, the mutarotation was accelerated and 
oligosaccharides were eluted as a single broad peak. However, sensitivity was 
greatly reduced due to ionisation suppression. Aqueous acid solutions were 
therefore considered as more suitable mobile phases for the glycosylation 
analysis of MAbs, with emphasis on structural elucidation of minor glycan 
species. The highest sensitivity was achieved when mobile phases containing 
acetic and propionic acid were used (Figure 3–1). As expected, the sensitivity 
was reduced approximately by an order of magnitude for ammonium buffer 
solutions due to the ionisation suppression. Sensitivity was also three-fold lower 
when formic acid was used instead of acetic acid, and the similar decrease in 
sensitivity was observed when ammonium formate and ammonium acetate were 
compared. Since the method development was also focused on identification of 
charged glycans in the MAbs, ammonium acetate was not excluded as a possible 
mobile phase in the analysis of real samples. The choice of suitable eluents for 
glycosylation analysis of RNase B and MAbs required a further reduction of 
glycans with sodium borohydride in order to avoid the undesirable separation of 
anomers.     
Variation in composition of the aqueous phase did not significantly affect the 
retention of the oligosaccharides, but it had a major effect on the ionisation of the 
oligosaccharides.  When ammonium was not present in the eluent, [M+H]+ 
pseudomolecular ions were the dominant species, however a low amount of 
[M+NH4]+ species was observed for all oligosaccharides (Figure 3–2A). It is 
suggested that ammonium originated from the sample. When ammonium 
buffers or ammonia were used, for larger oligosaccharides maltohexaose and 
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maltoheptaose, the strongest peaks observed were singly charged ammonium 
adducts and for the maltopentaose, the dominant peak was the protonated ion 
(Figure 3–2B).  
The results suggest that the tendency to form ammonium adducts increases with 
increasing molecular mass of the glycan. Similar results were observed for the 
glycan standards separated in the HILIC mode. Under both experimental 
conditions, neutral losses of water and one glucose residue were observed and 
the prominence of in-source fragmentation decreased in the following order, 
M5>M6>M7 (Figure 3–2). The fragment ions resulting from neutral loss of one 
glucose residue were observed only for protonated species, [M+H]+ and [M-
H2O+H]+, but not for ammonium adducts (not shown). The ionisation pattern 
suggests that ammonium stabilises oligosaccharides, similarly as reported for 
sodium adducts [101], therefore the ammonium adducts could not be 
fragmented in the ESI source. Since larger oligosaccharides exhibited greater 
preference to form ammonium adducts, the amount of in-source fragmentation 
decreased with increasing molecular weight, whereas the amount of ammonium 
adducts decreased in the reversed order.  
3.3.2. Separation of mannose glycan standards 
The same set of experiments was repeated for Man3 and Man9 glycan standards, 
which are more closely related to the glycans expected to be found in RNase B 
and the MAbs. For both mannose glycans, separation of anomers on graphitized 
carbon column was observed, except for the separation when ammonia solution 
was used as the eluent, which was in agreement with previously obtained results 
for linear oligosaccharides (Figure 3–3 and Figure 3–4). The same negative effect 
of ammonium on sensitivity as described for linear oligosaccharides was 
observed. The sensitivity for M5-M7 and Man3 glycans was also three-fold lower 
for formic acid than when acetic acid was used as the mobile phase. Opposite to 
M5-M7, Man9 glycan eluted earlier than the smaller Man3 glycan. Since the 
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separation mechanism of oligosaccharides on PGC is not completely understood 
[86], the elution order of glycans is harder to predict compared to HILIC.  
The effect of the mobile phase composition and pH on the retention of both 
glycans was negligible. However, differences in ionisation of Man3 and Man9 
glycans were observed. Man3 glycan with a molecular weight similar to linear 
maltopentaose exhibited a similar ionisation pattern with dominating singly 
charged protonated ion under all experimental conditions used. For Man3 
glycan, a neutral loss of water and one mannose residue was observed when 
acetic acid was used as a mobile phase; however, the intensity of fragment ions 
was very low (Figure 3–5A). Under all experimental conditions, a singly charged 
sodium adduct was present in the mass spectrum and no fragmentation was 
observed for this ion which is in agreement with results described above. When 
ammonium acetate was used as a mobile phase, only small peaks for ammonium 
and potassium adducts were observed (Figure 3–5B).  
On the other hand, the larger Man9 glycan tended to form doubly charged 
species and under certain conditions extensive in-source fragmentation was 
observed (Figure 3–6). When low concentrations of acids were used as the mobile 
phase, a series of doubly charged ions with similar intensity were observed, 
[M+2H]2+, [M+H+NH4]2+, [M+NH4+Na]2+. A strong singly protonated ion was also 
found in the mass spectrum. When acetic acid was used as an eluent, strong 
peaks for doubly protonated Man4 to Man8 fragment ions were observed; 
however the other doubly charged species of fragment ions were not found in 
the mass spectrum. The fragmentation pattern suggests that the doubly 
protonated ions are less stable in the ESI source, as previously observed for the 
oligosaccharides and this results in the neutral loss of mannose residues. It is 
suggested that formation of ammonium and sodium adducts stabilises the ions 
in the ESI source.  
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Figure 3–2: Average mass spectra over the maltopentaose, maltohexaose and 
maltoheptaose elution range. Gradient elution: mobile phase A-acetonitrile, mobile phase 
B-(A) 0.1% acetic acid, (B) 10 mM ammonium acetate pH 7.2. * Protonated species 
[M+H]+; ◊ protonated fragments with neutral loss of water *M-H2O+H]+; †ammonium 
adducts [M+NH4]+. 
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Figure 3–3: Base peak chromatograms of Man3 glycan at a concentration of 10 µg/ml. 
Gradient elution: mobile phase A-acetonitrile; mobile phase B-(a) 0.1% v/v formic acid, 
Vinj 5 µl; (b) 0.1% v/v acetic acid, Vinj 5 µl; (c) 0.1% v/v propionic acid, Vinj 5 µl; (d) 10 mM 
ammonium acetate pH 7.2, Vinj 10 µl; (e) 0.01% ammonia, Vinj 5 µl. When ammonium was 
present in the mobile phase, the sensitivity was reduced for an order of magnitude. 
When ammonia was used, the Man3 glycan eluted as a single broad peak. 
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Figure 3–4: Base peak chromatograms of Man9 glycan at a concentration of 20 µg/ml. 
Gradient elution: mobile phase A-acetonitrile; mobile phase B-(a) 0.1% v/v formic acid, 
Vinj 5 µl; (b) 0.1% v/v acetic acid, Vinj 5 µl; (c) 0.1% v/v propionic acid, Vinj 5 µl; (d) 10 mM 
ammonium acetate pH 7.2, Vinj 10 µl; (e) 0.01% ammonia, Vinj 5 µl. 
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Figure 3–5: Average mass spectra over the Man3 elution range. Gradient elution: mobile 
phase A-acetonitrile, mobile phase B-(A) 0.1% acetic acid, (B) 10 mM ammonium acetate 
pH 7.2. * Protonated species [M+H]+; ◊ protonated fragments with neutral loss of water 
[M-H2O+H]+; †ammonium adducts *M+NH4++; ● sodium adduct *M+Na++. 
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Figure 3–6: Average mass spectra over the Man9 elution range. Gradient elution: mobile 
phase A-acetonitrile, mobile phase B-(A) 0.1% acetic acid, (B) 10 mM ammonium acetate 
pH 7.2 ** Protonated species [M+2H]2+; *† proton and ammonium adducts [M+H+NH4]2+, 
*● proton and sodium adducts [M+H+Na]2+.    
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When ammonium was present in the eluent, the dominant peak found in the 
mass spectrum was the [M+H+NH4]2+ ion. A small peak for the singly charged 
ammonium adduct was also observed. The in-source fragmentation was almost 
negligible when ammonium acetate was used as a mobile phase. Only small 
peaks for doubly protonated fragment ions were observed in the mass spectrum, 
indicating the neutral loss of mannose residues. Again, the ionisation pattern 
suggested the stabilising effect of ammonium on fragmentation of glycans in the 
ESI source. The effect of mobile phase on the sensitivity of Man9 glycan was less 
pronounced compared to the smaller glycans used in the experiment. 
Understanding the ionisation of glycans in the ESI-MS source is vital for 
identification of glycans in complex real samples. Mobile phases containing 
acetic acid and ammonium acetate were selected as the most suitable mobile 
phases for further method development for separation of high mannose and 
complex-type glycans from RNase B and MAbs.  
3.3.3. Separation of glycans from RNase B  
PGC was used for the separation of glycans from RNase B and the 
chromatograms of high mannose glycans are shown in Figure 3–7. Acetic acid 
was used as an aqueous mobile phase in order to achieve optimum sensitivity. 
Truncated Man5-GlcNAc and Man6-GlcNAc glycans were found in the sample 
confirming the Endo H contamination previously observed for 2-AB labelled 
glycans separated by ZIC-HILIC. The truncated high mannose glycans exhibited 
lower retention on PGC compared to the PNGase F cleavage products. Opposite 
to the HILIC separation, the order of elution of Man5-Man9 glycans did not 
correlate with the molecular weight of the glycans. The most strongly retained 
was Man5 glycan, whereas Man6 to Man9 glycans were eluted in a very narrow 
elution window without a specific order. More important, the three Man7 
glycans were completely separated, which confirms the previously reported 
capability of graphitized carbon to separate structural isomers [37].  
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Figure 3–7: Extracted ion chromatograms of reduced glycans from RNase B obtained 
with graphitized carbon coupled with ESI-MS. Gradient elution: mobile phase A-
acetonitrile; mobile phase B-0.1% v/v acetic acid, pH 3.25. Three Man7 structural isomers 
are baseline resolved. A small amount of unreduced glycans is found in the sample, and 
was eluted after the corresponding reduced form. 
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For Man5-Man7 glycans, a strong singly charged protonated ion was observed 
(Figure 3–8), whereas Man8 and Man9 exhibited more complex mass spectra 
with singly and doubly charged species, as summarised in Table 3-1. This result 
is consistent with the data obtained for the reducing Man3 and Man9 glycan 
standards, indicating that ionisation of high mannose glycans depends on the 
size of the molecule, with higher preference for doubly charged ions for larger 
glycan species. 
The glycan profile of RNase B was consistent with the results previously 
obtained by amide HILIC and ZIC-HILIC. Furthermore, graphitized carbon 
allowed baseline separation of Man7 structural isomers, which in the HILIC 
mode were only partially resolved. 
 
 
Figure 3–8: Average mass spectrum of reduced glycans from RNase B obtained with 
graphitized carbon coupled with ESI-MS. Gradient elution: mobile phase A-acetonitrile; 
mobile phase B-0.1% acetic acid. For Man5-Man8 the strongest observed peaks are 
[M+H]+ ions, and for Man9 a number of singly and doubly charged ions were identified. 
Endo H cleavage products, Man5-GlcNAc and Man6-GlcNAc, are observed. 
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Table 3-1: Retention times and measured m/z for reduced glycans found in RNase B.  
Glycan 
composition 
Glycan Structure 
(m/z)theoretical, red  
[M+H]+ 
[M+2H]2+ 
Ions 
found 
Retention time / 
min 
(Man)3 
(Man)3(GlcNAc)1 
Man6-GlcNAc 
 
1196.43 
598.72 
[M+H]+ 6.7 
(Man)2 
(Man)3(GlcNAc)1 
Man5-GlcNAc 
 
1034.38 
517.69 
[M+H]+ 7.9 
(Man)4 
(Man)3(GlcNAc)2 
Man7 
 
1561.56 
781.28 
[M+H]+ 
9.9 
10.6 
11.0 
(Man)5 
(Man)3(GlcNAc)2 
Man8 
 
1723.61 
862.31 
[M+H]+ 
[M+2H]2+ 
10.0 
(Man)6 
(Man)3(GlcNAc)2 
Man9 
 
1885.67 
943.34 
[M+H]+ 
[M+2H]2+ 
[M+H+NH4]2+ 
10.2 
(Man)3 
(Man)3(GlcNAc)2 
Man6 
 
1399.51 
700.26 
[M+H]+ 10.6 
(Man)2 
(Man)3(GlcNAc)2 
Man5 
 
1237.46 
619.23 
[M+H]+ 13.6 
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3.3.4. Glycan profiling of monoclonal antibodies using PGC 
The use of graphitized PGC was also demonstrated for reduced glycans from 
monoclonal antibodies, which are summarised in Table 3-2. Symbols (a)-(l) are 
used for glycan chromatogram traces shown in Figure 3–9 to Figure 3–11. Similar 
glycan profiles compared to the profiles obtained by the HILIC amide and ZIC-
HILIC methods were expected; however, a few significant differences were 
observed. Opposite to the high mannose glycans, the order of elution of the most 
abundant G0, G1 and G2 complex-type glycans was the same as in the amide 
HILIC and ZIC-HILIC separation, where retention increased with increasing 
molecular weight. The difference in retention properties for high mannose and 
complex-type glycans suggested a more complex mechanism of interaction with 
the stationary phase which depends on the glycan composition, structure and 
size of the glycans.  
For MAb1 and MAb2 most of the glycans identified with the HILIC amide and 
ZIC-HILIC methods were found in the samples. Using the PGC column, a G0-
Fuc glycan was identified ((a) in Figure 3–9 and Figure 3–10), which was eluted 
before the G0-GlcNAc. The G0-Fuc glycan has not been identified by the 
standard amide HILIC method for the separation of 2-AB labelled glycans, but it 
was observed in the 2-AB labelled form when analysed by ZIC-HILIC. The 
results indicate that the new method is complementary to the standard 
procedure and the complete glycan profile could not be obtained by a single 
method only.  
Under the conditions applied, the G1 glycans were partially separated ((g), 
Figure 3–9 to Figure 3–11). For the G0-GlcNAc ((c), Figure 3–9 to Figure 3–11), 
several peaks were found, where the first peak belonged to the glycan and the 
later peaks were in-source fragments of G0 and G1. The fragmentation pattern 
suggests a neutral loss of terminal GlcNAc of non-galactosylated antenna in G0. 
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       Table 3-2: Proposed structures.and retention times of the reduced glycans found in MAbs. 
Glycan composition Symbol Possible structures 
(m/z)theoretical, red  
[M+H]+ 
[M+2H]2+ 
Ions 
found 
Retention 
time / min 
MAb1 MAb2 MAb3 
(HexNAc)2 
(Man)3(GlcNAc)2 
a / 
G0-Fuc 
  
1319.51 
660.26 
[M+H]+ 10.3 + + - 
(Hex)3(HexNAc)1  
(Man)3(GlcNAc)2 
b / 
Hyb2 
 
 
 
1602.59 
801.80 
[M+2H]2+ 12.2 - - + 
(HexNAc)1 
(dHex)1 
(Man)3(GlcNAc)2 
c / 
G0-GlcNAc 
  
1262.49 
631.75 
[M+H]+ 
12.6 
13.6 
14.4 
14.7 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
(HexNAc)2 
(dHex)1 
(Man)3(GlcNAc)2 
d / G0 
 
1465.57 
733.29 
[M+H]+ 
[M+2H]2+ 
13.6 + + + 
                     Table 3-2 continued< 
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(Hex)1(HexNAc)1 
(dHex)1 
(Man)3(GlcNAc)2 
e / 
G1-GlcNAc 
  
1424.54 
712.77 
[M+H]+ 
14.0 
14.4 
14.7 
15.5 
- - 
+ 
+ 
+ 
+ 
(Hex)2 
(Man)3(GlcNAc)2 
f / Man5 
 
1237.46 
619.23 
[M+H]+ 14.3 + + + 
(Hex)1(HexNAc)2 
(dHex)1 
(Man)3(GlcNAc)2 
g / G1 
 
1627.62 
814.31 
[M+2H]2+ 
[M+H]+ 
14.4 
14.7 
+ 
+ 
+ 
+ 
+ 
+ 
(Hex)3(HexNAc)1 
(dHex)1 
(Man)3(GlcNAc)2 
h / 
Hyb2F 
 
 
 
1748.65 
874.83 
[M+2H]2+ 
15.1 
15.7 
- - 
+ 
+ 
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(Hex)2(HexNAc)2 
(dHex)1 
(Man)3(GlcNAc)2 
i / G2  
 
1789.67 
895.34 
[M+2H]2+ 
15.5 
16.3 
17.0 
+ + 
+ 
+ 
+ 
(Hex)2(HexNAc)1 
(dHex)1 
(Man)3(GlcNAc)2 
j / 
G2-GlcNAc / 
Hyb1F 
 
 
 
1586.59 
793.80 
[M+2H]2+ 
13.2 
16.4 
- - 
+ 
+ 
(Hex)3(HexNAc)2 
(dHex)1 
(Man)3(GlcNAc)2 
k / G2+Gal 
 
1951.73 
976.37 
[M+2H]2+ 
17.2 
17.7 
- - 
+ 
+ 
(Hex)4(HexNAc)2 
(dHex)1 
(Man)3(GlcNAc)2 
l / G2+2Gal 
 
2113.78 
1057.39 
[M+2H]2+ 18.9 - - 
+ 
 
+ glycan was confirmed; - glycan not found in the sample. 
In-source fragmentation. 
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Figure 3–9: Base peak chromatogram and extracted ion chromatograms of reduced 
glycans from MAb1 obtained with graphitized carbon coupled with ESI-MS. Gradient 
elution: mobile phase A-acetonitrile; mobile phase B-0.1% v/v acetic acid, pH 3.25. G1 
glycan isomers are partially separated. Extensive in-source fragmentation (*) of terminal 
GlcNAc is observed. 
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Figure 3–10: Base peak chromatogram and extracted ion chromatograms of reduced 
glycans from MAb2 obtained with graphitized carbon coupled with ESI-MS. Gradient 
elution: mobile phase A-acetonitrile; mobile phase B-0.1% v/v acetic acid, pH 3.25. * In-
source fragmentation. 
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Figure 3–11: Base peak chromatogram and extracted ion chromatograms of reduced 
glycans from MAb3 obtained with graphitized carbon coupled with ESI-MS. Gradient 
elution: mobile phase A-acetonitrile; mobile phase B-0.1% v/v acetic acid, pH 3.25. 
Several isobaric structures of (h), (i), (j) and (k) glycan species are observed. Extensive in-
source fragmentation (*) of G0, G1and G2 glycan is observed.  
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However, the G1 fragmentation seemed more complex. For none of the G1 
isomers was the loss of galactose confirmed, and for both G1 glycan isomers, a 
fragment peak of G0-GlcNAc with the same intensity was observed, indicating 
the loss of GlcNAcGal fragment with no preference for either 3- or 6- arm of the 
glycans. 
A very low intensity peak was found for G1-GlcNAc glycan (not shown), with 
the same retention time as the first G1 glycan isomer, and it cannot be confirmed 
whether the peak represents the G1-GlcNAc glycan or an in-source fragment of 
the G1 glycan isomer. Extensive fragmentation in the position between the core 
mannose and GlcNAc of both arms, suggested the instability of this bond which 
was further destabilised by the terminal galactose. Abundant fragment ions 
resulting from loss of terminal GlcNAc have been previously observed for 
complex N-glycans [100]. The fragmentation will be further discussed by 
reference to the glycans from MAb3, which exhibited a different distribution of 
galactosylated glycan species and presence of α- and β-galactosylation. In MAb1 
and MAb2, which were expressed in CHO cells, only β-linked terminal galactose 
is expected to be found and the single peak observed for G2 glycan was in 
agreement with the theoretical prediction ((i) in Figure 3–9 and Figure 3–10). 
The glycan profile of MAb3 (Figure 3–11) exhibited greater complexity compared 
to MAb1 and MAb2, with several previously unidentified glycans observed. No 
defucosylated complex glycans were confirmed in this sample, and a different 
galactosylation pattern compared to MAb1 and MAb2 was observed. Single 
peaks were observed for G0 and Man5 glycans with single likely structural 
isomers. G1 structural isomers were partially separated, as observed already for 
MAb1 and MAb2. For the G2 chromatogram ((i) in Figure 3–11), three baseline-
separated peaks were observed. The first and the most intense peak exhibited the 
same retention as G2 glycans from MAb1 and MAb2 and indicated the presence 
of the glycan with 2 β-linked galactose units attached to two terminal GlcNAcs, 
which forms one possible structural isomer. The other two minor peaks most 
likely corresponded to two glycan isomers with two elongated galactose units on 
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one antenna, where the first galactose is β-linked to GlcNAc and the second one 
is α-linked to the galactose. No preference for either of the antennae is expected 
and similar peak intensity for both isomers is in agreement with the predicted 
structures.  
Two new structures, G3 and G4, which additionally confirmed the α-
galactosylation pattern in MAb3, were observed ((k) and (l) in Figure 3–11). For 
the G4 glycan a single peak was observed in the chromatogram which probably 
corresponded to the only likely structure containing two α-linked galactose 
residues on both of the antennae. On the other hand, for the G3 glycan two peaks 
were observed in the chromatogram, which most likely represent two structural 
isomers with an α-linked galactose on either of the antennae. Both isomers are 
likely to exist as structures represented in the Table 3-2.  
At 12.2 min a peak of defucosylated hybrid Hyb2 glycan species was observed 
((b), Figure 3–11), which could represent any of 3 possible structures in Table 3-2. 
Since the α-galactosylation was confirmed in MAb3, it is suggested that the α-
galactosylated structure is the most likely glycan species; however, structural 
elucidation is not possible for this chromatogram trace. As previously observed, 
the only defucosylated glycan species G0-Fuc, found in MAb1 and MAb2 was 
also eluted earlier compared to the fucosylated glycan form G0 ((a) and (d) in 
Figure 3–9 Figure 3–10). For the Hyb2F glycan ((h), Figure 3–11) which contains 
additional fucose compared to Hyb2, two peaks were observed and three 
possible hybrid structures with the same elemental composition are suggested, 
each with 3 hexose (galactose or mannose) residues (Table 3-2). Hyb2 and Hyb2F 
structures with GlcNAc on the 3-arm and mannose residues on the 6-arm are 
likely to exist in the MAb3 sample. With the existing data it was impossible to 
conclude which of the structures are present in the sample. 
For m/z=793.80 two peaks were observed, with very different retention 
properties ((j), Figure 3–11). Similarly as for Hyb2 and Hyb2F glycans, three 
possible glycan structures with the same elemental composition and various 
degrees of mannosylation and galactosylation were predicted. Since glycans 
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containing one GlcNAc generally exist only as the 3-arm isomers, all the three 
glycans are likely to exist in one structural form, as presented in Table 3-2. Due to 
the significant amount of α-galactosylation present in the MAb3, 
hypergalactosylated species G2-GlcNAc and a Hyb1F glycan seem to be the most 
likely candidates, however further analysis will be required to elucidate the 
possible structures of the two glycan species.   
Extensive in-source fragmentation was also observed in the MAb3 
chromatogram. For G0-GlcNAc and G1-GlcNAc several peaks were observed ((c) 
and (e), Figure 3–11). The first peak for both chromatogram traces corresponded 
to G0-GlcNAc and G1-GlcNAc glycans, and later peaks that overlap with G0, G1 
and G2, corresponded to fragments of these glycan species. It was again 
confirmed that the fragmentation occurred on the bond between the core 
mannose and GlcNAc. The neutral loss of GlcNAc and GlcNAcGal fragments 
was observed, where the loss of GlcNAc occurred on both G1 isomers with 
similar intensity and the loss of GlcNAcGal was more prominent on the early 
eluted G1 isomer. The results were not sufficient for the final conclusion of the 
terminal galactose position in G1 structural isomers; however, they indicated 
that stabilities of 3- and 6-linked GlcNAcs were not the same.  
The complex galactosylation pattern in MAb3 was not surprising, considering 
that MAb3 was expressed in NS0 murine cell line which exhibits α-
galactosyltransferase activity which is generally not found in CHO cells.  
Further MS/MS experiments in combination with exoglycosidase treatment will 
be required for complete structural elucidation of glycan species found in MAb3. 
However, it is noted that the MS/MS experiments alone may not be sufficient to 
confirm the isobaric structures containing mannose and/or galactose building 
blocks, since the fragmentation pattern of these glycan species would be very 
similar. On the other hand, treatment of glycans with various exoglycosidases 
(mannosidase, α- and β-galactosidase, fucosidase) will provide not only the 
information on terminal glycan residues but also the linkages.  
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The ionisation pattern for MAb glycans was significantly different to that of high 
mannose glycans from RNase B. The dominant ions were singly and doubly 
charged protonated ions, and ammonium adducts were observed for the 
oligomannosidic glycans. Again, the higher preference for doubly charged 
glycans was observed for larger glycans, as shown in Figure 3–12. For G0-
GlcNAc the main singly protonated ion was observed, whereas G0 exhibited two 
strong signals for [M+H]+ and [M+2H]2+, with lower intensity for the latter. The 
situation for G1 was reversed, with the stronger peak for doubly protonated 
species. For G2 and α-galactosylated glycans G3 and G4, only the [M+2H]2+ was 
found in the mass spectrum. 
 
Figure 3–12: Average mass spectrum of reduced glycans from MAb3 obtained with 
graphitized carbon coupled with ESI-MS. Gradient elution: mobile phase A-acetonitrile; 
mobile phase B-0.1% acetic acid. Singly and doubly protonated species were observed for 
G0 and G1 glycans. Doubly protonated forms were dominant for larger glycans. *Singly 
protonated ions; **doubly protonated ions.  
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It is important to emphasize that it is possible that under the conditions applied, 
the charged glycans may not have been eluted and absence of peaks for sialic 
acids containing glycans, observed with the HILIC amide separation of 2-AB 
labelled glycans, might not be due only to the low sensitivity. It has been 
previously suggested that for elution of charged glycans from the graphitized 
carbon column, a mobile phase with acid is not sufficient and ammonium buffers 
with certain ionic strength are required [87]. To see if any sialic acid-containing 
glycans can be detected, the glycans were separated on graphitized carbon using 
6 mM ammonium actetate pH 7.2 in water as an eluent B. When ammonium was 
present in the mobile phase, a significant suppression of ionisation was observed 
and only the peaks for the most abundant glycans were identified (not shown) 
and therefore the presence of sialic acids glycans could not be confirmed.  
It has been demonstrated that none of the described methods provided the 
complete glycan profile of the monoclonal antibodies and the separation using 
graphitized carbon gave complementary results with more detailed information 
about the presence of structural isomers in the sample and the less common 
glycosylation patterns, such as additional α-linked galactose in the antennae of 
complex glycans.   
3.4. Conclusions 
Graphitized carbon is shown to be a good alternative to HILIC in glycosylation 
analysis; however, none of the described HILIC and graphitized carbon methods 
provided the complete glycan profile of the monoclonal antibodies used in this 
study. Graphitized carbon is commonly used for separation of reduced glycans 
and coupled to ESI-MS. Compared to the standard method for separation of 2-
AB labelled glycans using HILIC amide coupled with fluorescence detection the 
graphitized carbon separation exhibits lower sensitivity, which is the main 
drawback of methods which do not include fluorescent labelling. On the other 
hand, the chromatographic run time was shorter compared to the previously 
described HILIC amide and ZIC-HILIC methods and expensive and time 
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consuming labelling was replaced by simple reduction using sodium 
borohydride. The graphitized carbon separation mechanism is not yet 
completely understood and the order of elution of glycans does not necessarily 
correlate with the size of glycans, as previously seen for HILIC separations. 
However, the graphitized carbon has superior capabilities for the separation of 
isobaric glycans compared to the HILIC columns used in this study and several 
structural isomers were successfully resolved using this method. The separation 
of structural isomers can be extremely important when monoclonal antibodies 
with more complex glycosylation patterns consisting of hybrid and highly 
galactosylated complex glycans with elongated antennae are being analysed. 
Frequently, a variety of structures with different branching or degree of 
mannosylation and galactosylation are possible for a single molecular mass. 
Although some of the isomers can be completely separated using graphitized 
carbon, structural elucidation is often not possible and analysis combined with 
exoglycosidases treatment may be required. It was demonstrated that the best 
sensitivity was achieved when a low concentration of acid was used as an 
aqueous mobile phase, although this promoted the in-source fragmentation of 
larger glycans. Ionisation of glycans was significantly suppressed when 
ammonium buffers were used as a mobile phase, which reduced sensitivity and 
resulted in the loss of signals for minor glycans species. No charged glycans were 
identified using graphitized carbon, probably due to two reasons. It is likely that 
the sialic acids-containing glycans were strongly retained by the stationary phase 
when low concentrations of acids were used as a mobile phase. When 
ammonium buffers were used, the sensitivity of ESI-MS detection was reduced 
due to the suppressed ionisation and low abundance negatively charged glycans 
could not be detected. The sensitivity of ESI-MS detection of reduced glycans 
could be enhanced by miniaturisation and this will be further examined in the 
following chapter.   
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Chapter Four 
 4. Nano LC separation of glycans 
4.1. Introduction 
An alternative strategy for glycan profiling with improved sensitivity is the 
separation of underivatized glycans using nanoscale LC coupled with mass 
spectrometric detection. The improved sensitivity is mainly due to lower 
chromatographic dilution in nano LC and improved ionisation efficiency in the 
nano ESI source [135]. Nanoscale graphitized carbon and HILIC amide stationary 
phases have been used for the separation of underivatized O- and N-glycans 
with low-femtomole sensitivity [75, 76, 88, 131, 136]. The nanoscale graphitized 
carbon columns have also been used in a microchip format [133]. The use of 
porous layer open tubular HILIC columns with 10 µm I.D. for sensitive glycan 
analysis with ESI-MS detection has also been demonstrated [137]. Recently, a 
chip-based reversed phase LC separation of permethylated glycans has also been 
reported [138].  
In this chapter, the use of nano ZIC-HILIC for a simple, rapid, and sensitive 
analysis of reduced high mannose and complex glycans from ribonuclease B and 
a recombinant monoclonal antibody is demonstrated. With this new method, 
higher sensitivity was achieved compared to the conventional approach. The 
ZIC-HILIC column exhibited different selectivity for neutral and sialylated 
glycans and a wide range of charged minor glycan species was identified. The 
nano ZIC-HILIC was coupled to a high resolution mass spectrometer which 
enabled study of structures that could not previously be identified by any 
current conventional approach.   
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4.2. Materials and Methods 
4.2.1. Sample preparation 
Glycoprotein samples (250 µg) were desalted prior to digestion using centrifugal 
filter units (Amicon Ultra, 10.000 MWCO, Millipore, Carrigtwohill, Ireland). 
Glycans were released from glycoproteins by incubation with 3 µL of PNGase F 
(500 units/mL, from Elizabethkingia meningoseptica); per 100 µL of 50 mM 
ammonium bicarbonate buffer, pH 8.0, overnight at 37 ˚C. Proteins were 
removed by precipitation with 400 µL ice-cold ethanol and dried in the vacuum 
oven overnight at 40 °C. The dried supernatants were reduced by adding 20 µL 
of 0.5 M sodium borohydride in 50 mM sodium hydroxide and incubating at 
room temperature overnight. The samples were then acidified by adding 5 µL of 
glacial acetic acid and desalted by ion-exchange chromatography (Dowex MR-3 
mixed bed, Sigma). Prior to analysis, the samples were diluted by a factor of ten 
in acetonitrile and 2 µL of the sample was injected onto the column. 
4.2.2. Nano ZIC-HILIC coupled with ESI-MS 
Nano ZIC-HILIC chromatography was performed with a Merck SeQuant (Umeå, 
Sweden) nano ZIC®-HILIC column (75 µm I.D. x 150 mm) with 5 µm particle 
size. The analyses were performed on a Dionex Ultimate 3000 HPLC system, 
including a ternary low-pressure-mixing gradient pump (DGP-3600) equipped 
with a membrane degasser unit (SRD-3600), a temperature-controlled column 
oven with a flow manager (FLM-3100) and a thermostated autosampler (WPS-
3000T). Mobile phase A and B consisted of acetonitrile and 2 mM ammonium 
acetate in water, pH 6.9, respectively. The flow-rate was set to 600 nL/min and 
the temperature of the column was maintained at 40 °C. Ribonuclease B and 
MAb3 glycans were analysed using gradient elution, starting with a 3 min 
isocratic step at 10% B, followed by a linear gradient from 10 to 45% B in 15 min 
and finished with a wash step at 95% B for 5 min. Prior to the next injection, the 
column was equilibrated for 25 min at 10% B. The LC system was coupled to the 
high resolution orthogonal TOF MS (MaXis™, Bruker- Daltonik, Bremen, 
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Germany). The transfer capillary was kept at a voltage of - 4500 V (positive ion 
polarity mode) or 3500 V (negative ion polarity) respectively. The nebulizer was 
set to 0.6 bar using an ESI nano sprayer (Bruker, Bremen, Germany), the dry gas 
temperature to 180 °C and the dry gas flow rate to 3 L/min. The ion transfer was 
optimized in the range m/z 200-3000 for highest sensitivity while keeping the 
resolution R>50,000 across the whole mass range. The TOF MS mass calibration 
was carried out prior to the LC-MS experiment by direct infusion of a 100 fold 
dilution of ES Tuning Mix (Agilent Technologies, Waldbronn, Germany) at 4 
µL/min. 
4.3. Results and discussion 
4.3.1. Separation of high mannose glycans released from RNase B 
RNase B is a glycoprotein with a molecular weight of approximately 15 kDa 
containing a single N-linked glycosylation site for high mannose glycans with 5 
to 9 mannose units and several possible structural isoforms [139]. Prior to the 
separation, the PNGase F released glycans were reduced to avoid a complex 
chromatogram resulting from the presence of anomers.  The glycan profile of 
RNase B obtained by ZIC-HILIC nano LC-ESI-TOF-MS in positive ion mode is 
shown in Figure 4–1. The expected order of elution according to the glycan size 
was achieved; the glycans with higher molecular weight exhibited longer 
retention times. The observed behaviour was in agreement with the accepted 
HILIC separation mechanism. All high mannose glycans were eluted over a 3 
minute range and most of them were baseline resolved. Some unreduced glycans 
present in the sample led to additional peaks being observed in the base peak 
chromatogram (BPC). The high resolution of the mass spectrometer enabled a 
clear distinction to be made between the reduced and unreduced peaks, which 
can otherwise give a partially overlapping pattern. All high mannose glycans 
exhibited a similar ionisation pattern, with dominating doubly charged 
[M+H+NH4]2+ ions. Singly charged protonated and sodiated molecular ion was 
observed for the Man5 glycan, however with increasing molecular weight the 
Chapter Four  Nano LC separation of glycans 
- 108 - 
 
proportion of doubly charged species increased. In-source fragmentation was 
observed for singly and doubly protonated ions, with the loss of one or two 
mannose residues (Figure 4–2). Less fragmentation was observed for 
[M+H+NH4]2+ ions, which indicated the stabilizing effect of NH4+ ion. It has been 
previously reported that oligomannosidic glycans are prone to in-source 
fragmentation depending on the solvent composition [37]. Compared to the 
original procedure, the complete analysis time was reduced from 105 min to 48 
min, with a 70 fold increase in sensitivity which results from the lower 
chromatographic dilution of the sample. The mass sensitivity in 
chromatographic detection increases with the inverse square of the column 
diameter and lower flow-rates additionally improve the ionisation efficiency in 
nano ESI [135]. RNase B glycans are summarised in Table 4-1. 
  
 
Figure 4–1: Separation of reduced high mannose glycans from RNase B. Gradient elution, 
10 to 45% B; mobile phase A (acetonitrile) and mobile phase B (2 mM ammonium acetate 
pH 6.9 in water); ESI-MS, positive ion mode. High resolution extracted ion 
chromatograms (hrEIC), m/z: (Man5) 627.7451±0.002; (Man6) 708.7715±0.002; (Man7) 
789.7979±0.002, (Man8) 870.8243±0.002; (Man9) 951.8507±0.002. 
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Figure 4–2: Accumulated mass spectrum over the RNase B glycan range; positive ion 
mode, background subtracted. *Doubly charged protonated species; †doubly charged 
[M+H+HN4]2+ species. Protonated ions are more prone to in-source fragmentation. 
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Table 4-1: Reduced glycans released from the RNase B. 
Glycan Structure Abbr. 
Retention 
time / min 
Ions 
Mtheoretical 
[M+H]+/Da 
Mmeasured deconvoluted 
[M+H]+/Da 
Δmass / ppm 
(Man)3(GlcNAc)2 
 
Man3 NA 
[M+2H]2+ 
[M+H]+ 
913.35071 913.35214 -1.6 
(Man)1 
(Man)3(GlcNAc)2  
Man4 NA 
[M+H+NH4]
2+ 
[M+2H]2+ 
[M+H]+ 
1075.40353 1075.40498 -1.3 
(Man)2 
(Man)3(GlcNAc)2  
Man5 23.8 
[M+H+NH4]
2+ 
[M+2H]2+ 
[M+H]+ 
[M+Na]+ 
1237.45635 1237.45556 0.6 
(Man)3 
(Man)3(GlcNAc)2  
Man6 24.6 
[M+H+NH4]
2+ 
[M+2H]2+ 
[M+NH4]
+ 
[M+H]+ 
1399.50918 1399.50828 0.6 
(Man)4 
(Man)3(GlcNAc)2  
Man7 25.2 
[M+H+NH4]
2+ 
[M+2H]2+ 
 
1561.56200 1561.56185 0.1 
(Man)5 
(Man)3(GlcNAc)2  
Man8 25.7 
[M+H+NH4]
2+ 
[M+2H]2+ 
 
1723.61482 1723.61387 0.6 
(Man)6 
(Man)3(GlcNAc)2  
Man9 25.9 
[M+H+NH4]
2+ 
[M+2H]2+ 
 
1885.66765 1885.66682 0.4 
 GlcNAc;  Man; NA-not assigned, observed only as in-source fragments of larger glycans.  
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4.3.2. Separation of glycans originating from monoclonal antibody  
Reduced MAb3 glycans were analysed using nano ZIC-HILIC coupled with ESI-
TOF-MS. The same gradient conditions as for high mannose glycans were used 
due to expected similar retention properties, as described previously. The lower 
retention of complex glycans compared to the high mannose glycans with 
comparable mass, Figure 4–3, was consistent with the results obtained on 
conventional size ZIC-HILIC. Using nano ZIC-HILIC, higher sensitivity 
compared to conventional ZIC-HILIC chromatography was achieved. The MAb3 
glycan sample was measured in positive and negative ion mode which allowed 
identification of all previously observed glycans commonly present in this 
monoclonal antibody (Table 4-2; h-k), which are generally of the biantennary 
complex type. Furthermore, nine new peaks for low-abundant glycans were 
observed with the proposed structures summarised in Table 4-2 (a-g, l-m). When 
2-AB labelled glycans from the same MAb were analysed by amide HILIC 
coupled with fluorescence detection, several minor species were observed. 
However, due to the lower sensitivity of MS in comparison to fluorescence 
detection and lack of appropriate standards, they have not been previously 
characterised [81].  
For all the known complex glycans, the dominant ions in the positive ion mode 
were doubly charged protonated ions (Figure 4–4), which is different to the high 
mannose glycans, where under the same experimental conditions predominantly 
the [M+H+NH4]2+ has been observed. The difference in the ionisation pattern 
suggests that the formation of pseudo molecular ions depends strongly on the 
structure of the glycan and it is expected that the same structural type of glycans 
will exhibit the same ionisation pattern. The doubly charged protonated ions 
could be predicted for peaks that were not previously observed using a 
conventional-size column.   
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Figure 4–3: Separation of reduced glycans from the MAb3. Gradient elution, 10 to 45% B; 
mobile phase A (acetonitrile) and mobile phase B (2 mM ammonium acetate pH 6.9 in 
water); ESI-MS, positive ion mode. HrEICs, m/z: (a) 866.3192±0.002; (b) 967.8589±0.002; 
(c) 947.3456±0.002; (d) 1048.8853±0.002; (e) 955.3431±0.003; (f) 1028.3720±0.005; (g) 
1129.9117±0.005; (h) 631.7476±0.002; (l) 1057.3930±0.003; (m) 976.3666±0.002; (G2)  
895.3401±0.002; (G1) 814.3137±0.002; (G0) 733.2873±0.002. The proposed structures are 
listed in    Table 4-2. 
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   Table 4-2: Reduced glycans released from the MAb3. 
Glycan Structure Abbr. 
Retention 
time / min 
Ions 
Mtheoretical 
[M+H]+ / 
Da 
Mmeasured 
deconvoluted 
[M+H]+ / 
Da 
Δmass / 
ppm 
(Hex)1(HexNAc)1 
(dHex)1(NeuGc)1  
(Man)3(GlcNAc)2  
a / 
G1-
GlcNAc+NeuGc 
21.4 [M+2H]2+ 1731.63114 1731.63040 0.4 
(Hex)1(HexNAc)2 
(dHex)1(NeuGc)1  
(Man)3(GlcNAc)2  
b / 
G1+NeuGc 
21.8 
[M+2H]2+ 
 
1934.71052 1934.71046 0.0 
(Hex)2(HexNAc)1 
(dHex)1(NeuGc)1  
(Man)3(GlcNAc)2  
c / 
Hyb1F+NeuGc 
21.9 
[M+2H]2+ 
 
1893.68397 1893.68235 0.9 
(Hex)2(HexNAc)2 
(dHex)1(NeuGc)1  
(Man)3(GlcNAc)2  
d / 
G2+NeuGc 
22.2 
[M+2H]2+ 
[M+3H]3+ 
2096.76334 2096.76136 0.9 
(Hex)3(HexNAc)1 
(NeuGc)1  
(Man)3(GlcNAc)2  
e / 
Hyb3+NeuGc 
22.3 
[M+2H]2+ 
 
1909.67888 1909.67934 -0.2 
(Hex)3(HexNAc)1 
(dHex)1(NeuGc)1  
(Man)3(GlcNAc)2  
f / 
Hyb3F+NeuGc 
22.3 
[M+2H]2+ 
 
2055.73679 2055.73537 0.7 
(Hex)3(HexNAc)2 
(dHex)1(NeuGc)1  
(Man)3(GlcNAc)2  
g / 
G3+NeuGc 
22.6 
[M+2H]2+ 
[M+3H]3+ 
2258.81616 2258.82237 -2.7 
                           Table 4-2 continued< 
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 GlcNAc;  Man;  Fuc;  Gal;  NeuGc 
(HexNAc)1 (dHex)1 
(Man)3(GlcNAc)2  
h / 
G0-GlcNAc 
22.8 
[M+2H]2+ 
 
1262.48799 1262.48923 -1.0 
(HexNAc)2 (dHex)1 
(Man)3(GlcNAc)2  
i / G0 23.5 
[M+2H]2+ 
 
1465.56736 1465.56786 -0.3 
(Hex)1(HexNAc)2 
(dHex)1  
(Man)3(GlcNAc)2  
j / G1 24.1 
[M+2H]2+ 
 
1627.62018 1627.61994 0.1 
(Hex)2(HexNAc)2 
(dHex)1  
(Man)3(GlcNAc)2  
k / G2 24.7 
[M+2H]2+ 
[M+3H]3+ 
1789.67301 1789.67291 0.1 
(Hex)3(HexNAc)2 
(dHex)1  
(Man)3(GlcNAc)2  
l / G3 25.1 
[M+2H]2+ 
[M+3H]3+ 
1951.72583 1951.72641 -0.3 
(Hex)4(HexNAc)2 
(dHex)1  
(Man)3(GlcNAc)2  
m / G4 25.5 
[M+2H]2+ 
[M+3H]3 
2113.77865 2113.77827 0.2 
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Figure 4–4: Accumulated mass spectrum over the MAb3 sialylated (A) and neutral (B) 
glycan elution range obtained by nano ZIC-HILIC; positive ion mode, background 
subtracted. Doubly protonated ions [M+2H]2+ are observed for the complex-type glycans. 
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Figure 4–5: Separation of reduced glycans from the MAb3. Gradient elution, 10 to 45% B; 
mobile phase A (acetonitrile) and mobile phase B (2 mM ammonium acetate pH 6.9 in 
water); ESI-MS, negative ion mode. HrEICs from top to bottom, m/z: (a) 864.3036±0.005; 
(b) 965.8432±0.005; (c) 945.3300±0.005; (d) 1046.8697±0.01; (e) 953.3274±0.005; (f) 
1026.3564±0.010; (g) 1127.8961±0.01; (h) 629.7320±0.005; (m) 1055.3773±0.010; (l) 
974.3509±0.005; (G2) 893.3245±0.005; (G1) 812.2981±0.005; (G0) 731.2717±0.005. 
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Figure 4–6: Accumulated mass spectrum over the MAb3 sialylated (A) and neutral (B) 
glycan elution range obtained by nano ZIC-HILIC; negative ion mode, background 
subtracted.  
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Considering high mass accuracy, two possible glycan structures with the same 
elemental composition can be predicted for most of the observed peaks. The 
average error in mass determination for most of the glycans was below 2 ppm. 
With the achieved high mass accuracy it is possible to predict a limited number 
of possible structures for the observed ions. Two probable  series of seven related 
complex and hybrid glycans which were eluted before the neutral G0, G1 and G2 
glycans could be identified, either containing a combination of dHex1NeuGc1 or 
Hex1NeuAc1 residues of which the first is more likely to occur in the sample, as 
will be further discussed. For the ion (e), only one possible structure can be 
assigned which confirms the presence of NeuGc in the sample. This result is 
consistent with the fact that the MAb3 was expressed in a NS0 murine cell line 
which is known to produce glycans with a high content of NeuGc [15]. In 
addition, the high degree of fucosylation in the cell line producing the MAb3 
leads to the deduction that the glycans observed belong to the group of core-
fucosylated complex and hybrid glycans containing NeuGc rather than NeuAc. 
The structures (a-g) in the Table 4-2 most likely correspond to the peaks observed 
in the chromatogram (Figure 4–3). The relative intensities for the proposed 
complex sialylated glycans are higher than those of hybrid sialylated glycans 
(Figure 4–4), which is in agreement with the high content of neutral complex 
glycan species in the sample.  
Elution of glycans containing sialic acid prior to elution of the neutral glycans 
indicated that the separation of glycans was not governed by hydrophilic 
interaction alone, but also by electrostatic repulsion between the ZIC-HILIC 
stationary phase and the glycans. This contributed to the earlier elution of 
negatively charged glycans.  The observed behaviour of negatively charged 
glycans under the applied conditions was expected due to the low ionic strength 
of the mobile phase, where the repulsion interaction was not shielded effectively 
by the eluent counter-ions. The electrostatic repulsion interaction has been 
previously observed for 2-aminopyridine labelled sialic acid glycans [80]. Under 
the conditions applied, the proposed hybrid glycans were eluted later than 
complex biantennary glycans with similar molecular weight, which is in 
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agreement with the previous observation that the high mannose glycans were 
retained more strongly compared to complex glycans of the same size.  
Other minor species observed in the sample were the highly galactosylated 
complex glycans (l, m), which were eluted after the G2 peak. The presence of 
these glycans in the MAb3 was consistent with the other species observed in the 
sample and as expected their retention time increased with the higher degree of 
galactosylation. Due to the α-galactosyltransferase activity observed in murine 
systems, hypergalactosylated glycans with additional α-linked galactose 
attached to the terminal β-linked galactose can be expected to be found in MAbs 
expressed in NS0 cell line [18]. 
The MAb3 glycans were also analysed under the same separation conditions in 
the negative ion mode. For all the neutral and charged glycans, the doubly 
deprotonated ions were observed (Figure 4–6) with the main peaks 
corresponding to the glycans observed in the positive ion mode. However, the 
overall sensitivity in negative ion mode was lower. In negative ion mode, better 
ionisation efficiency for glycans containing sialic acids was expected compared to 
that of the neutral glycans.  The relative peak intensity for the early eluted 
glycans was higher in the negative ion mode, which additionally confirmed the 
presence of sialic acids (Figure 4–5). The observed ionisation pattern allows the 
proposed glycan composition to be confirmed with high confidence. The mass 
spectrum of charged glycans obtained in the negative ion mode gave higher 
relative intensities for the proposed complex glycans compared to hybrid species 
(Figure 4–6A) and this was in agreement with the mass spectrum obtained in the 
positive ion mode (Figure 4–4A). Similar relative intensities in positive and 
negative ion modes were observed also for neutral glycans (Figure 4–4B and 
Figure 4–6B). 
The complexity of the sample and the presence of a wide range of minor species 
required downscaling to enable detailed characterisation of the glycan profile, 
which is not possible with conventional-scale columns due to the lower 
sensitivity obtainable. Significant information can therefore be lost when 
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conventional-scale columns are used. Alternatively, separation of fluorescently-
labelled glycans coupled with fluorescence detection might be necessary in order 
to ensure adequate sensitivity. Despite some advantages of fluorescence 
detection, such as high sensitivity and the possibility of relative quantification, 
this approach does not provide direct information about the structure of glycans 
and the profiling can be especially challenging when less common glycans are 
present in the sample. For the analysis of less abundant species the use of high 
resolution mass spectrometry may be required to confirm the composition with 
high confidence.  
4.4. Conclusions 
In this chapter, a rapid and sensitive technique for the HILIC separation of 
reduced high mannose and complex glycans using a nano ZIC-HILIC column 
coupled with high resolution ESI-TOF-MS has been described. It is demonstrated 
that downscaling can be an efficient way to enhance sensitivity. The new 
approach allowed glycan profiling without the need for fluorescence labelling. 
The column exhibited good selectivity for neutral and sialylated glycans and due 
to the improved sensitivity and high mass accuracy, the composition of several 
less abundant species could be identified. High resolution mass spectrometry has 
proven to be a powerful tool in glycosylation analysis as it enables structures 
with similar composition to be resolved. Using the new method, a range of 
charged glycans that were not previously observed by standard bore ZIC-HILIC 
was identified in MAb3 sample. Based on the fact that MAb3 originates from 
murine cell line and a high level of fucosylation and α-galactosylation was 
confirmed in this monoclonal antibody, it is suggested that the sialylated glycans 
contain NeuGc rather than NeuAc; however, for the complete structural 
elucidation, exoglycosidase digestions and tandem mass spectrometry will be 
employed in the following chapter. 
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Chapter Five 
 5. Exoglycosidase digestions and tandem mass spectrometry 
5.1. Introduction 
Due to the large number and complexity of glycan structures, various 
approaches for structural elucidation have been developed. The first common 
strategy involves LC separation of labelled glycans, in combination with 
digestions with highly specific exoglycosidases, either simultaneously or 
sequentially [47, 67]. Chromatography of standard glycans or MS is usually 
required for confirmation of structures, which makes this method extremely 
tedious and increases costs of the analysis. To simplify the assignment of 
chromatographic peaks, methods have been standardised and software for 
automatic prediction of structures has been developed [46].  
The second strategy for structural characterisation of glycans uses MS/MS, either 
on its own or in combination with LC or other separation techniques [48, 50]. The 
quality of structural information largely depends on the ions selected for 
fragmentation. Glycans can be fragmented in the native, labelled or 
permethylated forms. Fragmentation of protonated species is generally avoided 
due to poorly informative B- and Y-type glycosidic bond cleavages [100] and 
rearrangement reactions [107, 108]. More structural information can be obtained 
by fragmentation of sodiated species, which increases the amount of cross-ring 
cleavages [100]. Due to the improved MS sensitivity and quality fragmentation 
data, MS/MS often involves permethylation of glycans [98]. This method is 
highly suitable for MALDI-MS/MS analysis of glycans without prior separation 
and can also involve exoglycosidase digestions [48, 50]. Sample preparation has 
been greatly improved and enzymatic digestion can be performed directly on the 
MALDI target which simplifies the sample handling [53]. When combined with 
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LC, permethylation of glycans can represent an additional analytical challenge 
due to the loss of chromatographic resolution [132].  
In this chapter, both analytical approaches were employed for the 
characterisation of glycans observed by the PGC separation method and the 
suitability of both approaches was evaluated.  
5.2. Materials and Methods 
5.2.1. Reagents and chemicals 
α-galactosidase (from green coffee beans), α(2-3,6,8,9) neuraminidase (from 
Arthrobacter ureafaciens) and α-mannosidase (from jack bean) were obtained 
from Sigma (St. Louis, MO, USA). β-N-acetylhexosaminidase (from jack bean) 
was purchased from Prozyme (CA, USA). 
5.2.2. Sample preparation 
Monoclonal antibody (MAb3, 590 µg) was desalted prior to the digestion using 
centrifugal filter units (Amicon Ultra, 10,000 MWCO, Millipore). Glycans were 
released from MAb3 with 3 µL PNGase F (500 units/mL) digestion at 37 °C per 
100 µL of ammonium bicarbonate buffer (50 mM, pH 8.0) for 24 h. Proteins were 
removed by precipitation with 400 µL ice-cold ethanol and dried in a vacuum 
oven. The samples were reduced with 30 µL of 0.5 M sodium borohydride in 
0.025 mM sodium hydroxide in 50% ethanol (v/v) at room temperature 
overnight. The reaction was terminated by adding 5 µL of glacial acetic acid and 
the samples were desalted by ion-exchange chromatography (Dowex MR-3 
mixed bed, Sigma). The samples were dried in the vacuum oven prior to the 
exoglycosidase treatment. 
The exoglycosidase digestions were carried out using the following enzymes and 
conditions: α-galactosidase: 20 mU in 80 µL of 50 mM ammonium acetate pH 6.5, 
for 48 h, at room temperature; β-N-acetylhexosaminidase: 250 mU in 80 µL of 50 
mM ammonium formate pH 4.8 for 48 h, at 37 °C; neuraminidase: 2.5 mU in 80 
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µL of 50 mM ammonium formate pH 4.8 for 48 h, at 37 °C; α-mannosidase: 680 
mU in 80 µL of 250 mM ammonium formate pH 4.5 for 48 h, at 37 °C. The 
enzymes were removed prior to analysis by filtration using 10,000 MWCO 
centrifugal filter units. Analysis was done using the PGC method as previously 
described in Chapter 3. 
5.2.3. Tandem mass spectrometry 
The PGC separation method described in Chapter 3 was used for coupling with 
MS/MS. For the measurement of the effect of collision cell energy, it was raised in 
5 eV steps. Collision cell energy was used as noted.  
5.3. Results and discussion 
The most complex sample used in this study, MAb3, was further analysed to 
confirm the proposed structures. Several glycan species with multiple possible 
structures were observed in this MAb and two strategies were used in order to 
identify the unassigned peaks, observed by the PGC and nano ZIC-HILIC 
separation methods. The first strategy involved the use of exoglycosidases, 
which specifically cleave terminal residues, based on the type of the residue and 
the linkage. Additionally, the tandem MS analysis of glycans was used to obtain 
additional structural information. The advantages and limitations of both 
analytical strategies were compared.  
5.3.1. Exoglycosidase digestions 
Graphitized carbon was chosen as the most suitable stationary phase for analysis 
of neutral glycans from MAb3 due to the excellent capability to separate isobaric 
structures, as discussed in Chapter 3. The results of exoglycosidase digestions are 
summarised in Table 5-1. Compared to the experiments described before, 
additional glycan species, such as defucosylated complex and oligomannosidic 
glycans, were observed, since more starting material was used for the PNGase F 
digestion (Figure 5–1 to Figure 5–3). The presence of these species in the MAb3 is 
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not surprising; however, a series of less common glycans was identified and 
exoglycosidase digestions were used for confirmation of the proposed structures. 
For several observed m/z values in the control sample, multiple possible glycan 
structures can be assigned. Furthermore, for the same m/z chromatogram traces, 
several peaks were observed in the PGC chromatogram. Additional analysis is 
required to confirm whether the observed glycans are structural isomers or 
glycans with different monosaccharide composition. The high degree of 
galactosylation and mannosylation observed in MAb3 allows for a large number 
of possible hybrid structures.    
The most likely structures for observed m/z values are presented in the List of 
glycans (page XII). The proposed structures were selected based on the glycan 
mass and previous reports of glycans found with the GlycoMod tool 
(http://expasy.org/tools/glycomod/). The accurate mass was used for the 
determination of monosaccharide composition and all the measured m/z were 
within 20 mDa error range, which allowed confirmation of the composition with 
high confidence. Due to the acidic mobile phase used in the PGC separation 
method, the dominant ions were singly and doubly charged protonated ions. A 
preference to form doubly charged ions was observed for larger glycans. Where 
isobaric species were observed in the sample, a different ratio between the singly 
and doubly charged species was observed. This indicated a different glycan 
composition, most likely due to various degrees of galactosylation and 
mannosylation. 
MAb3 glycans were first analysed to confirm the presence of the α-galactose 
epitope, Figure 5–2, which is potentially immunogenic in humans and is 
expected to be found in the MAb expressed in a murine cell line. As described in 
Chapter 3, multiple peaks for m/z 895.34 and 976.37 and a peak for 1057.40 were 
found in MAb3. As previously suggested, the larger peak for m/z 895.34 was not 
affected by α-galactosidase digestion (Figure 5–4), which confirmed the 
proposed structure for this glycan with two β-linked galactose residues. 
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Figure 5–1: PGC separation of neutral reduced glycans found in MAb3, positive ion mode, BPC (m/z = 800-3000). Gradient elution: mobile phase A-
acetonitrile, mobile phase B-0.1% (v/v) acetic acid. The sample was highly heterogeneous with multiple low abundant isobaric complex and hybrid 
species. 
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Figure 5–2: PGC separation of neutral reduced glycans found in MAb3 after the digestion with α-galactosidase, positive ion mode, BPC (m/z = 800-3000). 
Gradient elution: mobile phase A-acetonitrile, mobile phase B-0.1% (v/v) acetic acid. Simpler gradient profile compared to the control was obtained. Some 
unreduced G0 was found in the sample and it was eluted later than reduced G0.   
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Figure 5–3: PGC separation of neutral reduced glycans found in MAb3 after the digestion with β-N-acetylhexosaminidase, positive ion mode, BPC (m/z = 
800-3000). Gradient elution: mobile phase A-acetonitrile, mobile phase B-0.1% (v/v) acetic acid. Strong peaks for degradation products of G0 and G1 were 
observed in the chromatogram. A low amount of unreduced glycans was present in the sample. 
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The other two minor peaks corresponded to two α-galactosylated G2 glycans. No 
preference for either of the antennae was expected and the similar peak intensity 
observed for both isomers was in agreement with the predicted structures. 
Additionally, two peaks for G3 and a peak for G4 glycans were found in MAb3, 
with confirmed terminal α-galactose. The similar peak intensity for G3 glycans 
suggested that there is no arm-preference for this structural motif as observed for 
α-galactosylated G2 glycan. On the other hand, only one peak was observed for 
G0-GlcNAc(-Fuc), G1-GlcNAc(-Fuc) and G2-GlcNAc glycan species, indicating 
the arm-preference when only one arm is elongated by GlcNAc, which is in 
agreement with previously reported structures found in the GlycoSuite database. 
It is suggested that GlcNAc is linked to the 3-arm of the core and the 6-arm is 
free or further mannosylated to form hybrid structures.  
α-galactosylation was confirmed in complex and hybrid structures; however, 
several peaks were found that could not be explained by α-galactosylation alone. 
The presence of isobaric hybrid species in the sample was also confirmed. By α-
galactosidase digestion it was possible to distinguish between the hybrid glycans 
with the same molecular weight and containing either mannose or α-linked 
galactose. However, without further digestions, it was not possible to conclude if 
the remaining hybrids were β-galactosylated or with the additional mannose on 
the 3-arm. N-acetylhexosaminidase and α-mannosidase digestions were 
performed to confirm the proposed hybrid structures. After the sample was 
digested with N-acetylhexosaminidase, the most abundant glycans G0 and G1 
could not be found in the PGC chromatogram and intense peaks for enzyme 
reaction products, fucosylated core and G1-GlcNAc, were observed (Figure 5–3). 
Furthermore, digestion of the G1 glycans resulted in an additional intense peak 
for G1-GlcNAc with GlcNAc cleaved from the 3-arm. Similar results were 
observed for G2-GlcNAc, as a digestion product of α-galactosylated G2 glycan. 
These results confirmed that glycans from MAb3 formed only one structural 
isomer, when there is only one complex-type antenna in the molecule, as 
previously suggested. 
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By using N-acetylhexosaminidase digestion is was possible to further confirm 
the proposed hybrid structures. If the hybrid glycans were not digested by the 
enzyme, it is suggested that the GlcNAc is further elongated by β-linked 
galactose. As shown for the chromatographic traces for m/z 1440.54, 793.80, and 
874.83, several isobaric hybrid species with various degrees of mannosylation 
and galactosylation were confirmed in the sample (Figure 5–5 to Figure 5–7). 
This practical example demonstrates the importance of the separation of glycan 
species with the same molecular weight to obtain complete information 
regarding the complexity of glycosylation in a given glycoprotein.  
Digestion with α-mannosidase provided additional information on 
mannosylation in the hybrid structures. As opposed to other enzyme reactions, 
α-mannosidase digestion was not complete. The result is not surprising, 
considering that some mannosidic linkages are more resistant to α-mannosidase 
cleavage. It is suggested that the α1→6 linkage is harder to digest compared to 
the α1→3 and α1→2 [6]. The digestion of glycans with the proposed free 6-arm 
was very poor, which was consistent with the fact that core mannose is 
extremely resistant to α-mannosidase digestions. Similarly, the proposed glycans 
with one mannose residue on the 6-arm were only partially digested, indicating 
the presence of an α1→6 mannosidic linkage. On the other hand, proposed 
hybrid glycans with two mannose residues on the 6-arm were readily digested, 
which confirmed the likely structures with α1→3 and α1→6 linkages in the 
glycan molecule. The presence of additional closely eluted peaks in α-
mannosidase digested samples suggests the possible presence of isomeric 
digestion products of higher mannosylated glycans. For the chromatogram trace 
m/z 793.80 (Figure 5–5), two hybrid glycans were proposed. The intense peak at 
13.2 min is most likely a hybrid structure with one α1→6 linked mannose on the 
6-arm, whereas the smaller peak at 14.9 min most likely corresponds to the 
structural isomer with an α1→3 linked mannose, as shown in Figure 5–5. The 
possible glycan structure with two mannose residues was excluded after the 
digestion with N-acetyhexosaminidase.  
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Figure 5–4: PGC EICs of G2 chromatogram trace (m/z 895. 34) prior to the digestion and 
after the digestion with α-galactosidase, β-N-Acetyhexosaminidase and α-mannosidase. 
Digestions with α-galactosidase and β-N-acetyhexosaminidase confirmed the presence of 
α-galactosylated epitope in late eluting low abundance G2 glycans. The same intensity of 
both peaks indicates that there is no arm-preference for β-linked galactose when two 
terminal GlcNAcs are present in the molecule.  
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Figure 5–5: PGC EICs of G2-GlcNAc glycan (m/z 793.80) prior to and after the digestions. 
α-galactosidase digestion confirmed the presence of α-linked galactose in the glycan 
eluting at 16.3 min. After the β-N-acetyhexosaminidase digestion, a new peak was 
observed, most likely corresponding to digestion product of G2 where GlcNAc was 
cleaved from the 3-arm of the glycan. After α-mannosidase digestion new peaks are 
observed, most likely the digestion products of different mannose cleavages from larger 
hybrid glycans.  
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Figure 5–6: PGC EICs of m/z 1440.53 prior to and after the digestions with α-
galactosidase. α-galactosidase digestion confirmed presence of the α-linked galactose in 
the glycan eluting at 13.8 min. β-acetylhexosaminidase and α-mannosidase digestions 
confirmed that the peak at 10.9 min contains terminal GlcNAc and most likely contains 
two mannose residues one of which is α1→3 linked.   
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Figure 5–7: PGC EICs of m/z 874.83 prior to the digestion and after the digestion with α-
galactosidase, β-N-acetylhexosaminidase and α-mannosidase. The digestions confirmed 
the proposed hybrid structures with none and one galactose residues on the 3-arm. Low 
abundant peaks could not be fully characterised.   
 
 
 - 134 - 
 
Table 5-1: Exoglycosidase digestions of glycans from MAb3. 
Glycan 
composition 
Proposed structures Abbr. 
Mtheor./ Da 
[M+H]+ 
[M+2H]2+ 
Ions 
found 
Control α-gal α-sialidase β-AcHex α-mann 
(HexNAc)1 
(Man)3(GlcNAc)2  
G0-
GlcNAc-
Fuc 
1116.4301 
558.7187 
[M+H]+ 
 
8.7 8.7 8.8 - 8.8 
(HexNAc)2 
(Man)3(GlcNAc)2  
G0-Fuc 
1319.5095 
660.2584 
[M+H]+ 
 
10.1 10.1 10.3 - 10.2 
(Hex)2(HexNAc)1 
(Man)3(GlcNAc)2 
 
 
Hyb1 
1440.5357 
720.7715 
[M+H]+ 
[M+2H]2+ 
10.2 
 
10.2 
 
10.3 
 
10.2 
 
10.2 
(Hex)4 
(Man)3(GlcNAc)2 
 
Man7 
1561.56 
781.28 
[M+H]+ 
[M+2H]2+ 
10.2 
10.9 
10.2 
11.8 
10.3 
11.0 
10.1 
10.8 
- 
- 
(Hex)2(HexNAc)1 
(Man)3(GlcNAc)2 
 
Hyb1 
1440.5357 
720.7715 
[M+H]+ 
[M+2H]2+ 
10.9 
 
10.9 
 
10.9 
 
- - 
(Hex)1(HexNAc)1 
(Man)3(GlcNAc)2  
G1-
GlcNAc-
Fuc 
1278.4829 
639.7451 
[M+H]+ 
 
10.9 10.9 11.0 10.9 10.9 
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(Hex)3 
(Man)3(GlcNAc)2 
 
Man6 
1399.5092 
700.2582 
[M+H]+ 
 
10.9 10.9 11.0 10.8 - 
(Hex)3(HexNAc)1 
(Man)3(GlcNAc)2 
 
Hyb2 
1602.5885 
801.7979 
[M+H]+ 
[M+2H]2+ 
12.2 
 
12.2 
 
12.2 12.1 - 
(HexNAc)1 
(dHex)1 
(Man)3(GlcNAc)2  
G0-
GlcNAc 
1262.4880 
631.7476 
[M+H]+ 
12.6 
13.5 
14.4 
14.6 
12.6 
13.5 
14.4 
14.7 
12.6 
13.6 
14.5 
14.8 
- 
- 
- 
- 
12.5 
13.5 
14.4 
14.7 
(HexNAc)2 
(dHex)1 
(Man)3(GlcNAc)2  
G0 
1465.5674 
733.28.73 
[M+H]+ 
10.9 
13.5 
11.0 
13.5 
11.2 
13.6 
- 
- 
11.1 
13.5 
(Hex)3(HexNAc)1 
(Man)3(GlcNAc)2  
Hyb2 
1602.5885 
801.7979 
[M+H]+ 13.1 - 13.2 13.1 13.2 
(Hex)2(HexNAc)1 
(dHex)1 
(Man)3(GlcNAc)2  
Hyb1F 
1586.5936 
793.8005 
[M+H]+ 
[M+2H]2+ 
13.2 
14.9 
13.2 
15.1 
13.3 
15.1 
13.1 
15.1 
13.3 
- 
(Hex)2(HexNAc)1 
(Man)3(GlcNAc)2  
Hyb1 
1440.5357 
720.7715 
[M+H]+ 13.7 - 13.8 13.7 13.7 
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(Hex)1(HexNAc)1 
(dHex)1 
(Man)3(GlcNAc)2  
G1-
GlcNAc 
1424.5408 
712.7740 
[M+H]+ 
11.9 
14.0 
14.4 
14.6 
15.4 
11.9 
14.1 
14.4 
14.7 
15.6 
12.0 
14.1 
14.5 
14.8 
15.6 
11.9 
14.0 
11.9 
14.0 
14.4 
14.7 
15.5 
(Hex)2 
(Man)3(GlcNAc)2 
 
Man5 
1237.4564 
619.2318 
[M+H]+ 14.3 14.3 14.2 14.1 - 
(Hex)1(HexNAc)2 
(dHex)1 
(Man)3(GlcNAc)2  
G1 
1627.6202 
814.3137 
[M+H]+ 
[M+2H]2+ 
12.1 
12.4 
14.4 
14.6 
12.2 
12.5 
14.4 
14.7 
12.3 
12.6 
14.5 
14.8 
- 
- 
- 
- 
12.2 
12.5 
14.4 
14.7 
(Hex)4(HexNAc)1 
(Man)3(GlcNAc)2 
 
Hyb3 
1764.6414 
882.8243 
[M+H]+ 
[M+2H]2+ 
14.7 - 14.9 14.9 - 
(HexNAc)3 
(dHex)1 
(Man)3(GlcNAc)2 
 
 
T0 
1668.6467 
834.8270 
 
[M+H]+ 
[M+2H]2+ 
15.0 15.1 15.1 - - 
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(Hex)3(HexNAc)1 
(dHex)1 
(Man)3(GlcNAc)2  
Hyb2F 
1748.6465 
874.8269 
[M+H]+ 
[M+2H]2+ 
- 
- 
15.0 
- 
- 
15.1 
- 
- 
15.1 
- 
- 
15.0 
14.4 
14.7 
14.9 
(Hex)2(HexNAc)2 
(dHex)1 
(Man)3(GlcNAc)2  
G2 
1789.6730 
895.3401 
[M+H]+ 
[M+2H]2+ 
15.4 15.6 15.6 15.5 15.5 
(Hex)1(HexNAc)1 
(dHex)2 
(Man)3(GlcNAc)2 
 
 
F1-
GlcNAc 
1570.60 
785.80 
[M+H]+ 
 
15.5 15.7 15.6 15.6 15.5 
(Hex)3(HexNAc)1 
(dHex)1 
(Man)3(GlcNAc)2  
Hyb2F 
1748.6465 
874.8269 
[M+H]+ 
[M+2H]2+ 
15.5 - 15.7 15.5 15.5 
(Hex)1(HexNAc)3 
(dHex)1 
(Man)3(GlcNAc)2 
 
 
T1 
1830.6996 
915.8534 
[M+2H]2+ 
15.9 
17.2 
16.1 
17.3 
 
16.1 
17.2 
 
- 
- 
16.0 
17.2 
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(Hex)1(HexNAc)2 
(dHex)2 
(Man)3(GlcNAc)2 
 
 
F1 
1773.6781 
887.3427 
[M+H]+ 
[M+2H]2+ 
16.1 
16.6 
16.1 
16.6 
16.3 - 16.2 
(Hex)2(HexNAc)1 
(dHex)1 
(Man)3(GlcNAc)2  
G2-
GlcNAc 
1586.5936 
793.8005 
[M+H]+ 
[M+2H]2+ 
16.2 - 16.4 16.3 16.3 
(Hex)2(HexNAc)2 
(dHex)1 
(Man)3(GlcNAc)2  
G2 
1789.6730 
895.3401 
[M+H]+ 
[M+2H]2+ 
16.1 
16.8 
- 
- 
16.2 
17.0 
- 
- 
16.2 
17.0 
(dHex)1 
(Man)3(GlcNAc)2  
G0-
2GlcNAc 
1059.4086 
530.2079 
[M+H]+ - - - 16.6 - 
(Hex)2(HexNAc)3 
(dHex)1 
(Man)3(GlcNAc)2 
 
 
T2 
1992.7524 
996.8798 
[M+2H]2+ 
 
16.7 
17.6 
 
16.8 
17.7 
16.8 
17.7 
- - 
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(Hex)2(HexNAc)2 
(dHex)2 
(Man)3(GlcNAc)2 
 
 
F2 
1935.7309 
968.3691 
[M+2H]2+ 
16.8 
17.2 
17.0 
17.4 
17.0 
17.2 
16.9 
17.2 
16.9 
17.2 
(Hex)3(HexNAc)2 
(dHex)1 
(Man)3(GlcNAc)2  
G3 
1951.7258 
976.3666 
[M+2H]2+ 
17.1 
17.5 
- 
17.2 
17.7 
17.1 
17.6 
17.1 
17.6 
(Hex)4(HexNAc)1 
(dHex)1 
(Man)3(GlcNAc)2  
Hyb3F 
1910.6993 
955.8533 
[M+2H]2+ 17.1 - 17.4 17.1 
- 
 
 
(Hex)3(HexNAc)3 
(dHex)1 
(Man)3(GlcNAc)2 
 
 
T3 
2154.8052 
1077.9062 
[M+2H]2+ 18.2 18.3 18.2 18.2 - 
(Hex)3(HexNAc)2 
(dHex)2 
(Man)3(GlcNAc)2 
 
 
F3 
2097.7837 
1049.3955 
[M+2H]2+ 
18.2 
18.8 
- 
18.4 
18.9 
18.3 
18.8 
18.2 
18.8 
              Table 5-1 continued< 
- 140 - 
 
(Hex)1(HexNAc)1 
(dHex)1 
(Man)3(GlcNAc)2  
G1-
GlcNAc 
  - - - 18.4 - 
(Hex)4(HexNAc)2 
(dHex)1 
(Man)3(GlcNAc)2  
G4 
2113.7787 
1057.3930 
[M+2H]2+ 18.8 - 19.0 18.9 18.9 
(Hex)2(HexNAc)1 
(dHex)1 
(Man)3(GlcNAc)2  
G2-
GlcNAc 
1586.5936 
793.8005 
[M+H]+ 
[M+2H]2+ 
- - - 19.9 - 
(Hex)3(HexNAc)1 
(NeuGc)1 
(Man)3(GlcNAc)2  
Hyb2+ 
NeuGc 
1909.6789 
955.3431 
[M+2H]2+ 27.1 25.0 - 24.3 - 
(Hex)2(HexNAc)1 
(dHex)1 (NeuGc)1 
(Man)3(GlcNAc)2  
Hyb1F+ 
NeuGc 
1893.6840 
947.3456 
[M+2H]2+ 28.4 26.0 - 25.5 23.0 
(Hex)1(HexNAc)2 
(dHex)1 (NeuGc)1 
(Man)3(GlcNAc)2  
G1+NeuGc 
1934.7105 
967.8589 
[M+2H]2+ 29.8 26.8 - - 24.1 
(Hex)3(HexNAc)1 
(dHex)1 (NeuGc)1 
(Man)3(GlcNAc)2  
Hyb2F+ 
NeuGc 
2055.7368 
1028.3720 
[M+2H]2+ 29.9 27.7 - 27.3 - 
(Hex)1(HexNAc)1 
(dHex)1 (NeuGc)1 
(Man)3(GlcNAc)2  
G1+NeuGc 
-GlcNAc 
866.3192 
1731.6311 
[M+H]+ 
[M+2H]2+ 
30.2 27.6 - 27.0 24.4 
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(Hex)2(HexNAc)2 
(dHex)1 (NeuGc)1 
(Man)3(GlcNAc)2  
G2+NeuGc 
2096.7633 
1048.8853 
[M+2H]2+ 30.5 27.6 - 26.9 24.9 
(Hex)3(HexNAc)2 
(dHex)1 (NeuGc)1 
(Man)3(GlcNAc)2  
G3+NeuGc 
2258.8162 
1129.9117 
[M+2H]2+ 31.9 - - 28.6 26.4 
 
Not explained, possible artifacts. 
In-source fragmentation. 
Structures excluded after exoglycosidase digestions. 
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All hybrid structures in the MAb3 sample were found in the fucosylated and 
defucosylated forms, whereas fucosylated species were dominant for complex 
glycans and only defucosylated high mannose glycans were found in the sample. 
Since fucose in generally attached to the glycan core after the glycoprotein has 
already been processed by mannosidase enzymes (Figure 1–2), this result is not 
surprising. A glycan profile with a large variety of unprocessed glycans suggests 
the lower activity of specific enzymes involved in the biosynthetic pathway of N-
glycans in this NS0 cell line.  
Using the improved procedure, sialylated species previously identified by nano 
ZIC-HILIC were observed in the PGC chromatogram of MAb3 glycans. As 
previously suggested, the charged glycans were much more strongly retained by 
PGC under the applied conditions, with broader peaks being observed compared 
to those of neutral glycans. Exoglycosidase digestions confirmed the proposed 
structures, which are mainly core-fucosylated containing NeuGc rather than 
NeuAc. NeuGc was expected for the MAb expressed in the murine system and is 
consistent with previously reported data.   
Using PGC with optimised sample preparation, another series of complex 
glycans with additional GlcNAc was identified that was not previously observed 
by any ZIC-HILIC method due to the low abundance (Figure 5–8). There are two 
likely series of glycans with the same monosaccharide compositions, either with 
an additional bisecting GlcNAc or a GlcNAc attached to one of the arms forming 
triantennary glycans. Since GlcNAc is usually β-linked to the core, it is difficult 
to distinguish between the two possible glycan series by using exoglycosidase 
digestions alone. However, some indications were found suggesting that 
triantennary glycans are more likely to correspond to the observed peaks. For the 
m/z 996.88, which most likely corresponds to one of the suggested structures 
with two additional galactose units on the antennae, several peaks were 
observed, indicating multiple positional isomers. For the glycan with bisecting 
GlcNAc, the possible isobaric structures would contain one β-linked galactose on 
each antenna or β- and α-linked galactose on either arm. The latter structural 
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motif was not consistent with the α-galactosidase digestion (Table 5-1, shaded in 
yellow). On the other hand, the triantennary glycan structures are consistent 
with the results of α-galactosidase digestion. These results are in agreement with 
the chromatograms for m/z 1077.91, where no α-galactosylation was confirmed 
which would indicate the presence of the glycan with bisecting GlcNAc. Two 
structures were therefore confirmed as triantennary and it is possible to deduce 
that all the observed glycans belong to the same structural group. 
Using PGC, a series of glycans with additional fucose (F1-GlcNAc, F1, F2, F3) 
was observed in the MAb3 sample (Figure 5–9). Using the GlycoSuite database 
(http://glycosuitedb.expasy.org/glycosuite/glycodb) two previously reported 
likely structures were found for most of the observed m/z values; one with the 
additional fucose linked to GlcNAc and the other with fucose linked to terminal 
galactose. Since this glycosylation pattern is quite unusual, further digestions 
with linkage-specific fucosidase are required to elucidate these structures. 
However, due to extremely low amounts of these glycans in the sample, further 
experiments have not been conducted. It is likely that all the observed glycans 
from the same glycoprotein would exhibit similar glycosylation pattern, as 
evident in the case of the hybrid and complex glycans found in this MAb. It is 
assumed that all the additionally fucosylated glycans belong to the same 
structural class and differ only in the degree of galactosylation. Another four 
peaks indicating possible terminal fucosylation, are early eluting G0, G1 and G1-
GlcNAc (shaded with green). However, it is possible that these peaks are 
artefacts. 
As demonstrated here, the use of PGC was extremely useful in analysis of highly 
complex samples, such as the glycans released from MAb3. Previously described 
HILIC approaches provided only limited information regarding the isobaric 
species present in the sample, and MS sensitivity was somewhat low due to a 
higher background originating from the higher acetonitrile content in the mobile 
phase. On the other hand, the use of PGC was found to be less suitable for the 
analysis of sialylated glycans due to poor reproducibility of the retention times of 
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charged glycans under the applied conditions, with retention decreasing over 
time. This could be due to ageing of the PGC surface [87]. It was shown that PGC 
is superior for structural elucidation of neutral isobaric glycans compared to 
HILIC, with more detailed information being provided for hybrid structures.  
However, the PGC method is less suitable for glycan quantification and routine 
analysis in quality control of biopharmaceuticals. It is believed that methods 
based on fluorescence detection will continue developing in the future due to the 
high sensitivity, quantitative analysis and simplicity of data interpretation. 
The improved sample preparation was used also for MAb1 and MAb2 samples; 
however, no additional glycans were observed by the PGC method. These results 
confirmed a more uniform glycan profile of the MAbs expressed in CHO cells, as 
observed also by amide HILIC and ZIC-HILIC approaches. 
 
 
Figure 5–8: EICs of triantennary glycans found in MAb3 obtained by PGC. Multiple 
isomeric structures were found for T1 and T2 chromatogram traces, whereas only one 
isomer was observed for T0 and T3 glycans.   
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Figure 5–9: EICs of fucosylated glycans found in MAb3 obtained by PGC. Two isobaric 
species were observed for F1-F3 glycans, indicating the presence of structural isomers. 
Only one peak was observed for F1-GlcNAc, most likely with the free 6-arm as 
confirmed for other glycan species in the sample. 
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5.3.2. Tandem mass spectrometry 
Glycans separated by graphitized carbon were further fragmented by collision 
induced dissociation (CID) in the QTOF mass spectrometer in order to evaluate 
the benefits and limitations of tandem mass spectrometry. Since acetic acid was 
used as the mobile phase, glycans were mainly detected as singly and doubly 
protonated species, which was expected to reduce the quality of fragmentation 
information. Fragmentation of protonated ions usually results in glycosidic bond 
cleavages producing B- and Y- type ions. This type of fragmentation generally 
provides information on monosaccharide residues constituting the glycan; 
however, information on branching and linkages cannot be obtained.  
Fragmentation under the applied conditions was studied on the most abundant 
high mannose and complex glycans, Man5 and G0, respectively (Figure 5–10 to 
Figure 5–12).  
The Man5 fragment spectrum was relatively simple with two glycosidic 
cleavages observed. As expected, Y-type cleavage of mannose and B-type 
cleavage of GlcNAc from the core with further fragmentation of B- and Y- 
fragments by successive losses of mannose residues was observed. The MS/MS 
spectrum was not very informative and only information on monosaccharide 
units could be obtained. Since the monosaccharide composition was already 
determined by accurate mass, tandem MS did not provide any additional 
information regarding glycan structure. 
The fragment spectrum of G0 glycan was more complex compared to the Man5 
spectrum. Since G0 formed intense singly and doubly protonated species, both 
ions were fragmented in order to choose optimum conditions for quality mass 
spectra (Figure 5–11 and Figure 5–12). Despite a lower collision energy used for 
fragmentation of the doubly protonated G0 ion, more extensive fragmentation 
was observed compared to the singly protonated ion, resulting in the loss of 
information on cleavages of terminal residues. Various collision energies were 
tested to achieve appropriate fragmentation conditions (not shown) and singly 
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protonated ions were selected as more suitable for further investigation. For all 
of the selected ions, glycosidic bond cleavage was observed, producing B- and Y- 
type fragment ions. As expected, for the Y ion series the loss of terminal GlcNAcs 
was observed, followed by the loss of fucose and mannose residues, respectively. 
On the other hand, B ion series exhibited unusual fragmentation pattern. For 
protonated core-fucosylated glycans, B-type cleavage of GlcNAcFuc residue 
from the reducing end is generally expected [100]. However, in the mass 
spectrum of G0 glycan, two B-type ions, 1039.38 and 1242.46, were observed. The 
first one most likely resulted from the loss of GlcNAcFuc residues at the 
reducing end of the molecule. The 1242.46 B-type ion indicated the loss of 
GlcNAc, which would not be possible without additional fucose transfer within 
the molecule. This result indicates the occurrence of rearrangement reactions 
which appeared as an internal loss of GlcNAc residue and could lead to incorrect 
interpretation of fragment spectra.  
 Tandem MS was used also for confirmation of the structure of Hyb2 glycan, 
eluted at 12.2 min, which was previously studied by exoglycosidase digestions 
(Figure 5–13).  As expected, the B- and Y- type fragmentations were observed. 
Both series of fragment ions suggest loss of hexose and subsequent loss of 
GlcNAc, which excluded the possibility of the hybrid structure with α-
galactosylation on the 3-arm, which was in agreement with the results obtained 
by exoglycosidase digestions. Since for all the glycans terminating with GlcNAc 
extensive loss of the GlcNAc residue was observed, it can be deduced that the 
fragment spectrum in Figure 5–13 belongs to the hybrid glycan with terminal 
galactose in the 3-arm. The proposed glycan is in agreement with other hybrid 
glycan species found in MAb3.  
It is noted that all glycan structures presented in this study were proposed based 
on literature reviews, previous reports, and knowledge of possible synthetic 
pathways found in the cell systems used for expression of the MAbs.   
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Figure 5–10: CID fragment spectrum of Man5 glycan, positive ion mode, collision cell energy 27 eV. 
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Figure 5–11: CID fragment spectrum of singly protonated G0 glycan, positive ion mode, collision cell energy 30 eV. 
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Figure 5–12: CID fragment spectrum of doubly protonated G0 glycan, positive ion mode, collision cell energy 17 eV.   
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Figure 5–13: CID fragment spectrum of doubly protonated Hyb2 glycan, positive ion mode, collision cell energy 31 eV. 
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Exoglycosidase digestions and tandem MS were used for confirmation of the 
proposed structures. However, none of the described methods provided 
sufficient information for absolute structural elucidation. Due to the large 
amount of information available on glycosylation of hamster and mouse systems 
available, the proposed structures can however be confirmed with high 
confidence.  
There are several limitations of the procedures used in this study. 
Exoglycosidase digestions require additional sample preparation; however, the 
higher the specificity of the enzyme, the more conclusive is the information on 
branching and linkages which can be obtained. 
MS on the other hand, provides information on the mass of the glycan. If high 
mass resolution analysers are used, measured accurate mass alone can provide 
sufficient information to deduce the monosaccharide composition, which would 
allow only a limited number of possible glycan species. As shown in this study, 
PGC is a highly suitable stationary phase for the separation of isobaric species, 
which enables further analysis of glycans either by tandem MS or exoglycosidase 
digestions. Since PGC separation with an acidic mobile phase, as used in this 
study, resulted in ESI formation of protonated ions, only limited information 
could be obtained by MS/MS. Another drawback of the proposed method was 
insufficient sensitivity. Since most of the hybrid and complex fucosylated and 
sialylated glycans of interest were present in the sample in extremely low 
amounts, it was impossible to obtain any quality MS/MS spectra. Possible 
rearrangements observed under the described conditions could provide 
misleading information, especially for glycans with additional fucosylation [107]. 
It is suggested that the proposed MS/MS approach is not suitable for structural 
elucidation, although some additional information may be obtained and MS/MS 
spectra of protonated glycans should be interpreted with great care.  
It is believed that better quality MS/MS information providing details on 
structures could be achieved in the negative ion mode [110]. Since sensitivity in 
the negative mode is much lower compared to the positive mode, this approach 
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could not be used in combination with the described PGC separation. It is 
suggested that the use of nano PGC could significantly improve MS sensitivity 
and therefore more structural information could be obtained either in positive, or 
even more likely, in negative ion mode [88].  
Another MS/MS based approach for structural elucidation would include 
permethylation of glycans to improve sensitivity and quality of fragment spectra 
with extensive cross-ring cleavages that could provide information on linkages 
and branching. In the case of complex samples with several isobaric species 
present, separation of permethylated glycans prior to MS/MS would be 
recommended; however, chromatographic resolution might be lower using this 
approach [132]. 
As shown in this study, currently there is no universal analytical approach that 
could provide complete information on glycosylation of complex samples. PGC 
was shown to be very useful for analysis of neutral glycans due to the high 
capability for separation of isobaric species; however, due to the ageing of the 
PGC surface stable retention times for sialylated glycans could not be achieved. 
Advantages and limitations of various approaches for structural elucidation 
were demonstrated for an extremely complex monoclonal antibody. 
Exoglycosidase digestions are commonly used in combination with separation 
techniques and MS based approaches. The sample preparation and LC analysis 
of digests are time consuming; however, the results are clear and easy to 
interpret. On the other hand, analysis of MS/MS spectra is extremely challenging, 
and the optimum results are usually achieved after permethylation of glycans. It 
is suggested that combination of separation and MS based strategies is required 
for detailed glycosylation analysis, either in the field of glycomics or in quality 
control of pharmaceutical glycoproteins.  
5.4. Conclusions 
Two approaches for structural elucidation, namely exoglycosidase digestions 
and tandem MS, coupled with chromatographic separation have been studied. 
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PGC was used as the most suitable stationary phase for separation of neutral 
glycans. It was shown that several isobaric species were separated using this 
approach and exoglycosidase digestions confirmed the proposed structures. 
Several isobaric species with various degrees of galactosylation/mannosylation 
were confirmed in the MAb3 sample, including the potentially immunogenic α-
galactose and NeuGc epitopes. 
The PGC method was further coupled to tandem MS. Due to the use of an acidic 
mobile phase, the most abundant protonated ions were selected for CID 
fragmentation. Using this approach, the extensive B- and Y-type glycosidic bond 
cleavages were observed for all selected ions, providing only limited information 
on glycan structure. Since most of the unknown glycans in MAb3 were present 
only in very low amounts, quality MS/MS spectra could not be obtained. Due to 
the lower sensitivity in negative ion mode, the method was not suitable for 
fragmentation of deprotonated species, although it is believed that negative 
MS/MS spectra could provide more structural information.  
It was shown that high resolution mass spectrometry can provide sufficient 
information on monosaccharide composition, which in combination with 
separation techniques and exoglycosidase digestions allows detailed analysis of 
very complex samples.  
Chapter Six  Conclusions and future work 
- 155 - 
 
Chapter Six 
 6. Conclusions and future work 
6.1. Project summary 
The aim of this project was to develop new methods for analysis of monoclonal 
antibody glycosylation in order to simplify the sample preparation, improve the 
separation and improve sensitivity in ESI-MS detection. Several new methods 
were developed using zwitterionic-type hydrophilic interaction chromatography. 
A model glycoprotein RNase B and three monoclonal antibodies expressed in 
different cell lines were used in this study. The new methods were compared to 
the standard procedure for separation of 2-AB labelled glycans performed on a 
HILIC stationary phase with amide functionality, as currently used in the 
pharmaceutical industry. It was demonstrated that ZIC-HILIC was a suitable 
stationary phase for separation of 2-AB labelled glycans and the method was 
coupled to fluorescence detection, which allowed relative quantification of 
glycan species. The method was optimised for on-line coupling with ESI-MS, 
which provided additional information on glycan composition. A significant 
difference in glycan profiles between MAbs expressed in CHO and NS0 cell lines 
has been observed; however, limited sensitivity did not allow the identification 
of minor glycan species in these samples. 
In order to simplify the sample preparation, the ZIC-HILIC column was tested 
for the separation of native and reduced glycans from RNase B and MAbs. Since 
chromatography of native glycans resulted in undesirable separation of anomers, 
the work focused on the separation of reduced glycans, which improved 
sensitivity and simplified chromatograms. Lower sensitivity compared to the 
fluorescence detection of 2-AB labelled glycans was achieved; however, all the 
major glycan species previously identified by the standard procedure were 
identified by the new proposed method.  
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To obtain a relevant comparison of methods for the separation of reduced 
glycans, a conventional graphitized carbon column was compared to ZIC-HILIC. 
The graphitized carbon column exhibited a superior capability for separation of 
reduced glycans and several isobaric species were effectively separated using this 
procedure. The sensitivity was higher than for the ZIC-HILIC method and 
several new glycan species were observed by this method. The graphitized 
carbon method confirmed the difference between the profiles of MAbs expressed 
in CHO cell line to that expressed in murine NS0 cell line. MAb3 from the murine 
expression system exhibited a relatively high degree of α-galactosylation, which 
was absent in the CHO MAbs. At the same time several hybrid structures were 
found in the glycan profile of MAb3. However, the graphitized carbon method 
alone was not sufficient for structural elucidation of glycan species found in 
MAb3 and for several observed m/z values, multiple structures with various 
degrees of mannosylation and galactosylation could be assigned.  
All the standard-bore methods used exhibited lower sensitivity compared to the 
standard amide HILIC procedure coupled with fluorescence detection and no 
charged glycans were confirmed in the MAbs, although low amounts of 
sialylated glycans were expected to be present in the samples. To improve the 
ESI-MS sensitivity of the ZIC-HILIC method for separation of reduced glycans, a 
nanoscale ZIC-HILIC column with internal diameter of 75 µm was employed. 
Using nano ZIC-HILIC, the sensitivity for neutral glycans increased 
approximately 70-fold, and seven negatively charged glycans were observed in 
the MAb3 sample. The nano ZIC-HILIC separation was coupled to a high 
resolution orthogonal TOF mass spectrometer, which enabled determination of 
glycan composition with high confidence. For six sialylated glycans two possible 
glycan structures could be assigned, either containing dHex1NeuGc1 or 
Hex1NeuAc1 combinations of glycan residues. Due to the fact that MAb3 was 
expressed in a murine cell line, a high level of fucosylation and the confirmed 
presence of NeuGc in the sample, it was suggested that the first combination is 
more likely. However, for the complete structural elucidation further 
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experiments were required. The nano ZIC-HILIC method confirmed once more 
the presence of hypergalactosylated glycan species in MAb3. 
Since many glycans species found using the ZIC-HILIC and PGC methods could 
not be structurally characterised, exoglycosidase digestions and tandem mass 
spectrometry were employed in the final part of the project. PGC was chosen to 
be the most suitable stationary phase for confirmation of the proposed neutral 
and sialylated glycan structures. By using PGC, several isobaric species with 
various degrees of galactosylation and mannosylation were confirmed in the 
sample, which revealed higher complexity of the MAb3 sample than suggested 
by the standard amide HILIC procedure. Exoglycosidase digestions also 
confirmed the presence of potentially immunogenic epitopes containing α-linked 
galactose and N-glycolylneuraminic acid. Furthermore, two series of previously 
unobserved triantennary and additionally fucosylated glycans were identified in 
MAb3. 
In contrast to the exoglycosidase digestions, tandem MS coupled with PGC 
provided only limited information on glycan structure. Due to the low 
abundance of the unknown glycans present in the MAb3 sample, quality MS/MS 
spectra for most of the species could not be obtained. Furthermore, due to the use 
of acidic mobile phase only protonated glycans could be selected for 
fragmentation, which exhibited only B- and Y-type cleavage of glycosidic bonds 
with no additional structural information. It was demonstrated that high 
resolution mass spectrometry can provide sufficient information on glycan 
composition, which in combination with a suitable separation technique and 
exoglycosidase digestions, allows detailed analysis of complex real samples.  
6.2. Suggested future work 
This project has investigated in detail two LC-based approaches for glycosylation 
analysis of monoclonal antibodies. Whereas ZIC-HILIC was shown to be suitable 
for the separation of fluorescently-labelled and reduced glycans, the PGC method 
was shown to be superior for the separation of reduced neutral isobaric species. 
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The proposed methods exhibited enhanced sensitivity, separation of isobaric 
species, and high resolution MS data and allowed identification of glycan species 
that could not be confirmed by the standard amide HILIC procedure. However, 
several questions regarding the structure of less common minor glycan species 
remain unanswered. For the structural characterisation of these glycan species 
further analysis employing highly specific exoglycosidases, possibly in 
combination with tandem MS, would be required. To obtain sufficient 
chromatographic resolution and ESI-MS sensitivity, the use of nano PGC would 
be suggested. The miniaturised system could potentially allow detection and 
fragmentation of the unknown species in negative ion mode, which could 
provide additional structural information. It is believed that downscaling, not 
only in nano column format but also in chip format, will become a standard in 
the glycosylation analysis.  
In this project, the use of ZIC-HILIC was demonstrated primarily on 
oligomannosidic and biantennary complex glycans which are expected to be 
found in monoclonal antibodies expressed in mammalian systems. It is suggested 
that the ZIC-HILIC stationary phase could be further tested for the separation of 
a broader spectrum of neutral and charged glycan species, which could increase 
its applicability in biotechnology and glycomics research.     
Sensitivity and quality of fragmentation data for structural elucidation and 
quantification could be additionally improved by permethylation. When complex 
samples with multiple isobaric species are to be analysed, the method would 
require separation of glycans prior to MS detection. Development of new 
methods and stationary phases for separation of permethylated glycans could be 
required to achieve suitable chromatographic resolution of closely related glycan 
species and structural isomers. Furthermore, additional fluorescent tags could be 
tested for use in combination with ZIC-HILIC or PGC in order to improve 
chromatographic separation or sensitivity in ESI-MS and fluorescence detection. 
Due to the good selectivity of ZIC-HILIC for the separation of neutral and 
charged glycans either in reduced or 2-AB labelled form, it is believed that 
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labelling with 2-aminobenzoic acid could be compatible with this stationary 
phase.  
There is a high demand for establishing databases of retention properties of 
glycans on various stationary phases for simpler assignment of chromatographic 
peaks. Currently, only databases for amide HILIC are generally available; 
however, some research groups develop their own databases of glycan structure-
retention properties for PGC. Simplified data analysis and peak assignment 
could make the new methods more attractive also for the use in glycomics 
research.  
6.3. Conclusions 
This project has investigated several techniques and approaches in glycosylation 
analysis of recombinant therapeutic monoclonal antibodies. Two strategies for 
glycan analysis were employed. The first approach was focused on separation of 
2-AB labelled glycans using two HILIC stationary phases coupled with 
fluorescence detection, whereas the other approach was focused on separation of 
reduced glycans in order to simplify the sample preparation, and miniaturisation 
which allowed MS detection of glycans with improved sensitivity. The 
combination of different approaches enabled detailed analysis of extremely 
complex real samples containing neutral and charged, complex and hybrid 
glycans. The newly developed methods were used in combination with 
exoglycosidase digestions and tandem mass spectrometry for the study of minor 
glycan species that are potentially immunogenic in humans. The practical value 
of rapid and sensitive methods for glycosylation analysis in quality control of 
biopharmaceuticals was demonstrated. Since the same principles apply to the 
analysis of glycans from organisms, glycomics may be another field for potential 
application of the presented methods.   
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